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Spondyloarthritis comprises a group of clinically and genetically closely related











especially with regard to development of new therapeutic options and the use of
magneticresonanceimaging(MRI)toestablishanearlydiagnosisofSpA.[6]Therecent
developments in the field of SpA increased the need to timely recognize patients
having the disease. However, several priorities on the research agenda to improve
earlier diagnosis remain, such as further refining the role ofMRI in the diagnosis,
followͲupandprognosisofpatientswithSpA.Also,improvingrecognitionandreferral
ofpatientswithearlySpA inprimarycare isan importantchallenge.Theaimof this
thesis is toprovidemore insight into the roleofMRI in SpAand recognitionof this
disease in primary care. This chapter first provides an overview of the current
knowledgeaboutSpAandthenelaboratesonthespecificobjectivesofthisthesis.
1.1Clinicalfeaturesofspondyloarthritis
InpatientswithaxSpA, themost importantclinical feature is inflammatorybackpain
(IBP)causedbysacroiliitisandspondylitis.[7]IBPistypicallycharacterizedbyawakening
night pain, improvement of pain with exercise, no improvement with rest and a
favourable response tononͲsteroidalantiͲinflammatorydrugs (NSAIDs).[8]Peripheral
SpA is characterized by peripheral arthritis (predominantly of the lower limbs),
enthesitis and dactylitis, as presenting symptom.[1] ExtraͲarticular manifestations




Although the clinical symptoms of the SpA are typically heterogeneous, there is
evidenceofsharedgeneticmarkersandlinkage.[10]Thestrongestknowncontributing
geneticfactorforSpA isthemajorhistocompatibilitycomplex (MHC)class Imolecule
human leukocyteantigen(HLA)ͲB27.HLAͲB27 ismoststronglyassociatedwithaxSpA.
TheriskofdevelopingaxSpAinHLAͲB27Ͳpositiveindividualsisashighas5–7%.[11,12]
Approximately 80Ͳ90% of Northern European patients with axSpA are HLAͲB27
positive.[11]OthersubtypesofSpAhave lowerdegreesofassociationwithHLAͲB27.
For instance, the frequency of HLAͲB27 in patients with psoriatic arthritis and
peripheralarthritisisaround20%,butthisincreasesto60%inpatientswithassociated
sacroiliitis.[13] More recently, additional genetic links that contribute to the
pathogenesis of SpA have been identified, e.g. polymorphisms of the interleukinͲ23
receptor (ILͲ23R) gene and endoplasmic reticulum aminopeptidase1 (ERAPͲ1) gene.
GeneticvariantsofILͲ23RarealsolinkedtoconcomitantpsoriasisandIBD.[11,12]
InpatientswithSpA, thegenetic susceptibility is,at least inpart, responsible foran
‘autoͲinflammatory status’. This autoͲinflammatory reaction may eventually initiate




0.5Ͳ1%,similarly to thatof rheumatoidarthritis.[14]TheestimatedprevalenceofAS,
the most frequent subtype of SpA, ranges from 0.1Ͳ0.9%.[14] The incidence and
prevalence rates of SpA are strongly dependent and directly correlated to the



























disorders e.g. rheumatoid arthritiswas first described by theAmericanRheumatism
Association in the “Nomenclature and Classification of Rheumatic diseases” in
1963.[17,18]Theunifyingconceptof“seronegativespondyloarthritides”,nowknown
as“spondyloarthritisorSpA”,wasfirstintroducedbyMollandWrightin1974.[19]
Over the last decades, several sets of classification criteria for SpA have been
developedinanattempttodefinesubgroupsofpatientstofacilitateresearchstudies.
Figure1 shows ahistorical timeline inwhich several classification criteria for SpA in
general,forAS,andforaxialandperipheralSpAarepresented.[7,20Ͳ23]
ThemodifiedNewYork (mNY)criteria for theclassificationofAS relyonclinicaland
radiologicalfindings(Figure1.1).[20]PatientsfulfilthemNYcriteriawhensacroiliitison
aconventionalradiographispresentandatleastoneclinicalcriterionispresent.[20]A
major disadvantage of themNY criteria is that advanced sacroiliitis on conventional
radiography is required for fulfilment. Development of radiographic sacroiliitismay

























































































































































































































































































































































































































developed inthe1990s, inordertoencompasstheentirespectrumofSpA, including
theaxialandperipheralmanifestations,andearlyaswellasmilddiseasestages.[21,22]





develop new criteria sets. The most recently developed criteria sets are the
AssessmentofSpondyloArthritis internationalSociety (ASAS)classificationcriteria for
axialandperipheralSpA.[7,23]Theentrycriterion fortheASASaxSpAcriteria isback
pain ш3monthsandageatonset<45years (Figure1.1).Thereare twoarms in the
ASASaxSpAcriteria,an “imaging”and “clinical”arm.The imagingarm includesboth
sacroiliitisdetectedeitherbyMRIoron a conventional radiograph; for classification
one other additional SpA feature also needs to be present. HLAͲB27 is the main
criterionof the clinicalarm; for classification twootheradditional SpA featuresalso









feature severalcriteria setshavebeendevelopedover the lastyears.[8,27,28]Single
parameters lacksufficientdiscriminativeability todefine IBP,becauseallparameters
mayalsobepresent inpatientswithothercausesofbackpain.[27]Themostrecent
criteria set for IBP is theASAS classification criteria set for IBP, established in 2009
(Figure1.2).[27]TheASAS IBPcriteriawere tested inavalidationcohortandhavea
sensitivityof77.6%andspecificityof72.4%,whenatleastfouroutoffiveparameters

























Conventional radiography is themost widely used imaging technique for assessing
structuralchangesoftheSIJs.[29,30]RadiographsoftheSIJscandemonstratesclerosis,
erosionsandankylosis.[31]Thepresenceofsacroiliitis isgraded from0 (normal)to4
(ankylosis)(Table1.1).[20]
The main disadvantage of conventional radiography in the clinical assessment of
patients suspected for having axSpA is its low sensitivity, especially in early
disease.[7,29]Inaddition,onlystructuraldamageoftheSIJs,whichistheconsequence



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































diagnosis of axial SpA.[34] By using MRI, both active (inflammatory) lesions and
structuralchangescanbevisualized(Table1.1).[34]TypicalactivelesionsintheSIJsare
subchondral bonemarrow edema (BME) / osteitis, and to a lesser extent synovitis,
enthesitisandcapsulitis.[34]ActivelesionsarebestvisualisedonT2fatsaturated(FS)Ͳ
weighted spinͲecho (SE) sequence,T1FSgadoliniumcontrastͲenhanced sequenceor
the short tau inversion recovery (STIR) sequence. Structural changes that can be
detected byMRI are erosions, fat deposition (fatty lesions), sclerosis and ankylosis.
ThesestructurallesionsarebestdetectedontheT1ͲweightedSEsequence.[34]
A positiveMRI of the SIJs in the context of identifying sacroiliitis, is defined as the
presenceofsubchondralBMEthatishighlysuggestiveofaxialSpA,andappearsastwo
ormoredistinguishablelesionsononeslice,orasonelesiononatleasttwosuccessive
slices (ASAS/ OutcomeMeasures in Rheumatoid Arthritis Clinical Trials (OMERACT)
definition).[34]Thepresenceofsynovitis,enthesitisorcapsulitiswithoutBMEdoesnot
suffice. Only active lesions (BME) are currently considered for fulfilment of the
ASAS/OMERACTdefinition.[34]Structuralchangesmayalsooccur inconjunctionwith
BME,orwithoutBMEasasequelofpreviousinflammation.[34]
Several scoringmethods for assessment and quantification of active lesions onMRI









duration isalsoassociatedwitha favourable response toNSAIDsandantiͲTNFͲalpha
therapy.[39] Furthermore, several studies have shown that effective treatment of





Thegeneralpractitioner (GP) isakey roleplayer in the identificationand referralof
patientssuspectedofhavingSpA.[44]However,knowledgeandawarenessaboutSpA
and theassociatedextraͲarticularmanifestations is lowamongGPs, resulting inpoor
recognitionanddelayed referralofpatients.[45]A recent studyhas shown that1 in
4patientswith chronic back pain of ш3months that had started before the age of
45yearsandwhowererecruitedfromprimarycare,canbeclassifiedashavingaxSpA
aftercarefulevaluation.[46]ThesepatientshadnotbeenrecognizedassuchbytheGP.
Several referral tools forpatientswith chronicbackpainhavebeenproposeda few
yearsago,inordertoimproverecognitionandhencereferralofpatientssuspectedfor
axSpA inprimarycare.[47Ͳ51]Thesetools includedparameterssuchasIBP,sacroiliitis
on imaging and / orHLAͲB27.When patients fulfilled the referral criteria andwere
actuallyreferredtotherheumatologist,upto45%patientswerefoundtohaveaxSpA
afteradiagnosticworkͲup.[48Ͳ52]




Until about the turn of themillennium, SpA took the back seat in rheumatology,
becauseoflimitedtherapeuticoptions.Earlydiagnosiswassimplynotanareaofmajor
concern.Thisdramaticallychangedwith the introductionof thehighlyeffectiveTNFͲ
alpha blockers that significantly improved quality of life of patients dealing with
SpA.[53]Theexpansionoftherapeuticarmamentariummakes itnecessarytoprovide
reliabledataon theprevalenceofSpA, inorder togain insight in thesocietal impact
andcostsassociatedwithSpA.
In addition, new and effective therapeutic optionsmake it evenmore important to
diagnose SpA at an early stage. In the light of these developments, the Early
SpondyloArthritisClinic (ESpAC)wasestablished in2000.[54]SixtyͲeightpatientswith
IBPoflessthantwoyearsdurationwereincludedinthisprospectivecohortstudyand
followed for twoyearswith repeatedclinicaland radiologicalexaminations. In2009,









developed inorder toshorten thediagnosticdelay that issocharacteristic for these
patients,butthesetoolscanonlybesuccessfulifknowledgeandawarenessaboutSpA


















of sacroiliitis in68patientswith recentͲonset IBP, included in theESpAC.Chapter3
describeshowactive lesionsonMRIof theSIJs inpatients included inESpACevolve
over time, and discusses which determinants are responsible for persisting active
lesionsonMRIoftheSIJs.Chapter4describestheassociationbetweenBMEonMRIof
the SIJs and development of structural changes on both MRI and conventional
 Generalintroduction~21
radiographs inpatients included intheESpAC.Toassessactive lesionsonMRIofthe
SIJs,severalMRIsequencescanbeused.InChapter5,thepotentialincrementalvalue
oftheT1postͲGdͲDTPAMRIsequenceofSIJscomparedtothecombinationoftheSTIR
MRI sequence and conventional radiographs is discussed. Chapter 6 describes the
naturalcourseofBMEonMRIoftheSIJsovera2ͲyearfollowͲupperiod.
Theoptimizationof identificationand referralofpatientssuspectedofhavingSpA in
primary care is described in ƉĂƌƚ /// of this thesis. Chapter 7 describes the level of
knowledgeandexperiencesofGPswithregardtoaxSpA.Chapter8describesastudyin
which the current practice performancewith regard to referral and recognition of
patientswithearlySpAwasinvestigatedbyusingstandardizedpatients.Inaddition,the
influenceofeducationonthisperformancewasalsostudied.Theresearchpresented
in this thesis is summarized and discussed in Chapter 9 and 10. Chapter 10 also
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effectsmodel,was 0.55% (95% CI 0.37Ͳ0.77); for ankylosing spondylitis (AS) 0.18%
(95% CI 0.15Ͳ0.23); and for psoriatic arthritis (PsA) 0.15% (95% CI 0.12Ͳ0.18), but
substantial heterogeneitywas revealed (I2 >99%). The following characteristicswere
significantlyassociatedwithvariation inprevalenceofSpA,ASand/orPsA:proportion
of females, mean age of the sample, geographic area and setting (demographical
characteristics); year of data collection, case finding, and case ascertainment
(methodological characteristics). For the other SpA subgroups too few studieswere





SpA isacommondisease,butwith largevariation in reportedprevalenceestimates,
which can partly be explained by differences in demographical andmethodological




Since itsestablishment in the1970s, thediseaseconcept spondyloarthritis (SpA)has
seen major developments with respect to identification and classification of the
disease,measurement and prediction of outcome, and treatment options.[1]While
SpA can be considered a condition itself, several subtypes can be distinguished,
including ankylosing spondylitis (AS), psoriatic arthritis (PsA), SpA related to
inflammatory bowel disease (IBDͲSpA), reactive arthritis (ReA) and undifferentiated
SpA (uSpA).[2] More recently, the Assessment of SpondyloArthritis international
Society (ASAS) proposed to distinguish axial from peripheral SpA, depending on the
predominantarticularmanifestationsofthedisease,anddevelopednewclassification
criteria.[3,4] The treatment possibilities in patients with SpA have improved
substantially in the lastdecadewith the introductionofbiologicals.On this line, it is
relevanttogaininsightintopatternsoftheprevalenceofSpAanditssubtypes,asthis
may contribute to our understanding of both the needs of healthcare systems Ͳ in
termsofavailabilityofhealthcareresourcesandbudgetsͲandtheetiopathogenesisof
thedisease.
Considerable variation in the reported prevalence of SpA has already been
recognized.[5] In particular, awide range of estimates across geographic regions is
found,which has classically been related to the presence of HLAͲB27.[6] However,
other yetunknowndemographical andmethodological characteristicsof the studies
may also play a role in this variation. ĞŵŽŐƌĂƉŚŝĐĂů characteristics refer to for
examplethemeanageofthesample,themale:femaleratio,orthegeographicregion.
DĞƚŚŽĚŽůŽŐŝĐĂů characteristics include for example year of data collection, sampling
frame,andcasefinding.









This systematic review was performed in accordance with the quality of reporting
metaͲanalysesofobservationalstudies(MOOSE)guidelines.[8]
Searchstrategy
MEDLINE (viaPubMed)andEMBASE (OVID)were searchedbetween1975Ͳ2014 July
1stforprimarystudies investigatingtheprevalenceofSpAoroneof itssubtypes.The
search strategy consisted of a combination of textwords and controlled vocabulary
terms (e.g. MeSH terms) relating to SpA and its subtypes, and to prevalence or
epidemiology. Thedetailed search strategy isoutlined in Supplementary File1. Two
reviewers independently reviewed titles and abstracts on eligibility criteria for
inclusion, afterwhich fullͲtextwas read. In addition,hand search of referenceswas
performed. If the fullͲtext of the articles could not be retrieved, authors were
contactedviaemail. Incaseofanydiscrepanciesbetween the tworeviewers,a third
reviewerwasconsultedforfinaldecision.
Selectioncriteria
Onlyoriginal researchstudies reportingprimarydataon theprevalenceofSpAor its
subtypes in the general populationwere included. Studieswere excluded if: 1) the













in these populations.[9,10] The setting was subdivided into urban, rural, or a
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combination of both. TheŵĞƚŚŽĚŽůŽŐŝĐĂů characteristicswere starting year of data
collection (or alternatively publication year if not reported), sampling frame, case
findingandcaseascertainment.Samplingframewassubdividedintocensus,household
register, convenience sample, general practitioner database, hospital database,
register, or a list of specific group of subjects (e.g. employees of a company). Case
finding was based on the procedure to identify cases and included selfͲreported





diagnosis (i.e. diagnosis by a physician) and classification criteria used for each SpA
subtype, such as the modified New York criteria for AS, the European
Spondyloarthropathy Study Group (ESSG) criteria, the ClASsification for Psoriatic
Arthritis(CASPAR)criteria,orASASSpAcriteria.[3,11Ͳ13]
Finally, data related to prevalencewere extracted (raw datawere extracted or the





shows the riskofbias tool including instructionsonhoweach itemwas scored.We
excludedtheitem“wasthelengthoftheshortestprevalenceperiodfortheparameter
of interestappropriate” from thechecklist,since thisquestion isnotapplicable fora
chronicdisease,suchasSpA.
Datasynthesisandanalysis
Because prevalence estimates were expected to be below 1%, the values were
transformed with the double arcsine transformation for metaͲanalysis and metaͲ
regression.[15]Thepooledprevalencewasestimatedby combining the transformed
prevalence estimates using a randomͲeffects model. Studies from Northern Artic
indigenous communitieswereexcluded from themetaͲanalysis,because the risk for
SpA inthisgroup isclearlydifferentfromtherestoftheworld,whichwouldbias(i.e.
overestimate) the results. The pooled prevalence and 95% confidence intervals (CI)
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were back transformed to prevalence estimates for ease of interpretation. The
heterogeneityamongstudieswastestedbytheCochran’sQtestandtheI2statistic,the
latterdescribingthepercentageofvariationacrossstudies.[16]
Potential sources of heterogeneity were investigated by an exploratory subgroup
analysis, using random effects analogous to oneͲway analysis of variance, inwhich
groups of estimateswere arranged according to potentially relevant demographical




Univariable andmultivariablemetaͲregression analyses were performed to explore
associations between demographical and methodological characteristics and the
prevalence.VariableswithapͲvalueof<0.20 intheunivariableanalysiswereentered
intothemultivariablemodel.Abackwardprocedurewasused,removingvariableswith
apͲvalueof>0.05 in themultivariablemodel inorderof significance. The following
variableswere tested:mean age of the sample, proportion of females, geographic
area, setting, year of data collection, case finding, case ascertainment, and the






The database search yielded 9,240 studies (Supplementary File 3). After removing
duplicatesandtitle/abstractscreening,179articlesremainedforfullpaperreview.Two
papers could not be retrieved, despite contacting the authors.[18,19] After fullͲtext
reading, 80 articleswere included.With hand search of references, 4 paperswere
added,leadingtoatotalof84articles.
Characteristicsofincludedstudies




15 studies (88 estimates).A detailed overview of all included studies is provided in
SupplementaryFile4.AcombinedmetaͲanalysisandmetaͲregressionanalysiscouldbe
performed forSpA,ASandPsA.Onlya limitednumberof studieswereavailable for
ReA, IBDͲSpA and uSpA, therefore these results are described and summarized
narratively.
Table 2.1 shows a summary of themain characteristics of studies included in the
largestgroups;SpA,ASandPsA.
Riskofbias




The pooled population prevalence of SpA was 0.55% (95%CI 0.37Ͳ0.77), with high
heterogeneity(I2=99.9%).Figure2.1showstheprevalenceestimatesofSpAaccording
todifferentdemographicalandmethodologicalcharacteristics.Meanageofthestudy
population and geographic area contributed significantly to the observed
heterogeneity. The prevalence of SpA was higher in studies from North America
(1.35%,95%CI0.44Ͳ2.79,n=1study)andEurope (0.54%,95%CI0.36Ͳ0.78)compared
with South Asia (0.22%, 95%CI 0.01Ͳ0.66) and SouthͲEast Asia (0.20%, 95%CI
0.00Ͳ0.66). No studies from SubͲSaharan Africa, Central Asia and Oceania were
available (Figure 2.2a).With respect to the sampling frame, true population studies


































































































































































































































































































































































































































































































































































































































































































































































Figure2.1 Prevalence of spondyloarthritis grouped by demographical andmethodological characteristics.
Estimates of Northern Artic communities were not included in the subgroupͲanalysis.
ESSG=European Spondyloarthropathy Study Group; ASAS= Assessment of Spondyloarthritis
InternationalSociety.
AxialandperipheralSpA
Twostudies reported theprevalenceofaxialand/orperipheralSpAaccording to the
ASAS classification criteria.[20,21] In a large populationͲbased cohort consisting of
20,625 employees of the French national electricity and gas company, a crude









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































was high (I2=99.0%). Figure 2.3 shows the pooled prevalence of AS stratified by









in sampleswitha lowerpercentageof females (p<0.01),differentacrossgeographic
areas (higherprevalence rates in studies fromNorthAmerica,EuropeandNorthern
Articindigenouscommunitiescomparedwithallothergeographicregions),andhigher
insamplesfromruralareascomparedwithurbanareas(p<0.01).Theprevalencewas
lower insamples inwhichcaseswere foundbymedical recordscomparedwith twoͲ





prevalence of PsA was significantly different across age groups and related to
geographic area (Figure 2.2c). The highest prevalencewas found in Europe (0.19%,
95%CI 0.16Ͳ0.32) and the lowest in theMiddle East (0.01%, 95%CI 0.00Ͳ0.17). The
prevalenceofPsAwasfurthersignificantlyrelatedtosamplingframeandcasefinding.










































































finalmodel explained 44.7% of the total heterogeneity. A highermean age of the
samplewaspositively related to theprevalenceofPsA (p<0.01)andprevalencewas
significantly different across geographic areas.With respect to themethodological
characteristics, prevalencewas significantly higherwhen case findingwas based on
selfͲreportcomparedwithmedicalrecords.
Reactivearthritis
TheprevalenceofReAwasreported in17studies:6 fromEurope,1 fromSouthͲEast
Asia,1fromSubͲSaharanAfrica,and9fromNorthernArcticindigenouspopulations.In
Europe, the prevalence of ReA ranged from 0.03% in Greece to 0.21% in
Lithuania.[22,23]InastudyfromIndia,inwhich8,145individualswereinterviewed,no






IBDͲSpA. In these 4 studies, classificationwas based on the ASASͲcriteria, the ESSG
criteriaincombinationwithIBD,orICDcodes.[20,22,28,29]
Undifferentiatedspondyloarthritis
The prevalence of uSpAwas reported in 15 studies.Different criteriawere used to









SpA (0.55%, 95%CI 0.37Ͳ0.77), AS (0.18%, 95%CI 0.15Ͳ0.23) and PsA (0.15%, 95%CI
0.12Ͳ0.18). Heterogeneity across studies was high, therefore estimates should be
interpretedwithcaution.ForReA,IBDͲSpAanduSpAtoofewstudieswereavailableto
conduct ametaͲanalysis and, therefore, results were only summarized. Prevalence
estimates of ReA (range 0.0%Ͳ0.2%), IBDͲSpA (range 0.0%Ͳ0.1%), and uSpA (range
0.0%Ͳ0.7%)weregenerallylow.
Thisstudy is the first thatpooledprevalencesofSpAand itssubtypes in thegeneral
population, and additionally investigated demographical and methodological
characteristics influencing the estimates. Geographic area was in themultivariable
metaͲregression analysis one of the most important characteristics explaining
heterogeneity in prevalence estimates of SpA. This variation might particularly be





with reported HLAͲB27 prevalences in these areas.[37] A relatively high pooled
prevalenceofSpAwas found inNorthAmerica,however,theestimatescame froma
single study with a high risk of bias.[38] In this study, the prevalence of SpA was
estimatedaccordingtotheESSGandtheAmorcriteria,resulting inestimatesof1.4%
and 0.9% respectively.[38] This finding also illustrates that the choice of different







positivelyand independently related to theyearofdatacollectionwithmore recent
studies reporting higher prevalences. This may either be a true increase in the
prevalence of SpA, or,more likely, an increased awareness and recognition of SpA.
Further,prevalenceestimateswerehigherinstudieswherepopulationswerescreened
forSpAcomparedwith studies inwhichcaseswere identified frommedical records.
 Theglobalprevalenceofspondyloarthritis~43
Thisfindingsuggeststhatthere isunderͲrecognitionofSpA. Inthesubgroupanalyses
this is supported by the fact that sampling form census lists yielded the highest
prevalence.With respect to caseascertainment,no significantdifferencewas found
betweenclassificationbasedontheESSGcriteriacomparedwithclinicaldiagnoses.In
thepresentreview,toofewstudiesusingthenewASAScriteriawereavailabletodraw
a conclusion.Future studiesareneeded togainmore insight into the impactof the
ASAScriteriaon theprevalenceofSpA inpopulationstudies,althoughapplicationof




hemisphere. Further, the prevalence of AS was higher in the male population.
Traditionally,ASisconsideredasadiseasepredominantlyoccurringinmales,although
it has been shown that thismay in part be an artefact induced by deficits in the
diagnosisofASinfemales.[40Ͳ42]NonͲradiographicaxialSpA,ontheotherhand,isas
common in female as in male subjects, indicating that females develop structural
changes lateror less frequently thanmales.[39,43] In contrast, no difference in the
prevalence of PsA in gender distribution was found with the multivariable metaͲ
regression. The prevalence of PsA, however, was significantly related to age, and
peakedintheagecategorybetween50and60years.





in prevalencemight exist, for example betweenNorth and South Europe.However,
further subdivisionwouldhavehampered themetaͲregression analysis. Third,direct
comparisonsbetween the resultsof themetaͲanalysesandmetaͲregressionanalyses
ofSpA,AS,andPsAarehampered,becauseoftenpopulations fromdifferentstudies
wereused.Last,metaͲregressionanalysis itselfhassome limitations.[44]Resultsfrom
metaͲregressions are observational, and therefore, can suffer from bias by
confounding. Patients’ characteristics are based on groupͲaverages, and the
relationshiponstudy levelmaynotbe thesameas the relationshiponpatient level.
Consistent with these concerns, high risk of bias was found for the items on





SpA and its subtypes. A large part of the heterogeneity could be explained by
geographic characteristics. However, also other demographical andmethodological
characteristics, such as the proportion of females, year of data collection and case
finding accounted for the observed variation. The results also suggested that there
mightstillbeanunderͲdiagnosisofSpA.Itistobeexpectedthatbetterrecognitionof
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Todescribehow inflammationonMRIofthesacroiliac joints inpatientswithrecentͲ




A 2Ͳyear followͲup studywith annualMRI of the sacroiliac jointswas conducted in
patientswithIBPof lessthan2years’duration.Imageswerescoredforbonemarrow






6patients (15%) developed activity onMRI during followͲup. TwentyͲfour patients
(35%)hadanabnormalMRIatbaseline.In23ofthese24patientsfollowͲupMRIwas
available.TheMRIbecamenegative in7ofthese23patients(30%)duringfollowͲup.
HLAͲB27 positivity and male gender determined independently the likelihood of a
positiveMRI at any time point. In an HLAͲB27 positive patient the likelihood of a
positiveMRI during followͲup is 88% if the baselineMRI is positive and 27% if the









The concept of spondyloarthritis (SpA) covers a family of seronegative rheumatic
disorders that share distinct clinical and genetic characteristics. General symptoms
include inflammatory back pain (IBP), peripheral arthritis, enthesitis, dactylitis and
anterioruveitis.Ankylosingspondylitis (AS) istheprototypeofSpAwithpredominant





mainly because available classification criteria were considered too insensitive,
especially in early and mild disease.[6] Although not intended for this purpose,
classification criteria are frequently used in daily practice. As a consequence, the
diagnosisofAS isoftendelayed for10 years, sinceaccording tomodifiedNewYork




of sacroiliitis, months to years before structural damage can be detected on a
conventionalradiograph.[8]
Although activity (inflammation) detected on MRI is considered an important
manifestationinearlySpA,thereisstilluncertaintyabouthowactivityonMRIevolves
over time.MRI followͲup studies inpatientswith a shortdurationof symptoms are
limited.Oostveenetal.suggestedthatchronicchangesonradiographsarepreceded
by inflammatory lesions onMRI.[8]More recently, Bennett et al. showed that both
severe sacroiliitis on MRI at baseline as well as HLAͲB27 positivity predict the
developmentofabnormalitieson radiographs8years later.[9] It is,however,unclear
whetheractivityinthesacroiliac(SI)jointsasseenonMRIisstableovertime,becomes
quiescentafteran initialperiodofactivity,or fluctuatesover time.Moreknowledge










Patients with IBP of less than 2 years’ duration were included in the Early
SpondyloArthritisCohort(ESpAC)study.Thedetailsofthisstudyhavebeendescribed
previously.[10] In brief, IBP was defined according to the Calin criteria, and was
consideredpresent if4outof5ofthe followingcriteriawerepresent:onsetofback
painbeforetheageof40yearswithapersistenceofatleast3months,insidiousonset,














following sequenceswere used in an oblique coronal orientation: T1Ͳweighted spin
echo(SE),shortʏinversionrecovery(STIR),T2weightedfastSEwithfatsaturationand
T1Ͳweighted SE with fat suppression (FS) after administration of the intravenous






TheMR imageswere scored using a combination of the Spondyloarthritis research
Consortium of Canada (SPARCC)method and amodified version of theAarhusMRI
scoringmethod.[14,15] The SI joints were divided into four quadrants: upper iliac,
lower iliac,upper sacraland lower sacral. Incontrast to theoriginalSPARCC system,
therewasnomaximum to thenumberofevaluatedslices, inorder tomaximise the
detectionofabnormalMRfindings.Thetotalnumberofevaluatedslices in individual
patients remained stable. Inflammation in the cartilagenous part of the joint was
scoredpersliceinadichotomousmanner(presentvs.absent).Bothsubchondralbone
marrowedemaandenhancementafteradministrationofGdͲDTPAwerescored.Bone
marrow edema was defined as areas of increased signal intensity on STIR images






edema, includingadditionalscores fordepthandhighsignal intensitycomparable to
enhancedvessels,respectively.
AnMRIwasconsideredpositive foractivesacroiliitisaccordingtotheASAS/Outcome
Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) MRI working group
definition:thepresenceofatleastoneactivelesioninatleasttwosuccessiveslicesor
thepresenceofmore thanone lesion inonlyone slicewhich ishighly suggestiveof
sacroiliitis.[16]
Statisticalanalysis
TheMRI scoreswere analyzed and described in three differentmanners. First,we
describedtheMRIstatusovertime(positiveornegative).Second,wehaveinvestigated
the likelihoodofhavingapositiveMRIatanytimeduringfollowͲup,aswellasfactors
determining MRIͲpositivity, making use of generalized estimating equation (GEE)
analysis forbinomialoutcome variables,withMRI statusasdependent variable,and
HLAͲB27statusandgenderas independentexplanatoryvariables.Thecontributionof
CͲreactiveprotein (CRP) inexplainingapositiveMRIwastestedbyaddingCRP inthe
modelasacovariate.GEEisanappropriatetechniquetostudytimetrendsindatasets
withmissing values while adjusting for withinͲpatient correlation. Thirdly, we have







In total,68patientswith IBPwere included in thisstudy.Baselinecharacteristicsare
shown in Table 3.1. Details of these patients have been described previously.[10]
NinetyͲseven percent of all patients fulfilled at least four out of five Calin criteria.
Almost half of the patients was HLAͲB27 positive. Anterior uveitis and IBD were
reported in10 (15%)patientseach,and16 (24%)patientshadahistoryofpsoriasis.























The values are expressed as number (percentage) of patients or as stated otherwise. ESpAC=Early





least one followͲupMRI after 1 or 2 years followͲup and 44 patients completed all
 ActivelesionsonMRIofthesacroiliacjoints~79
3examinations. Table 3.2 shows theMRI status (positive or negative) at baseline
according to theASAS/OMERACTMRIworkinggroupdefinitionaswellashow these
findingsdevelopovertime.
Intotal,44patients(65%)hadanegativeMRIatbaseline,ofwhich15patients(34%)
wereHLAͲB27positive.Of these44patients,39 (89%)completedeitheroneor two
followͲupMRIs. Insixof these39patients (15%), theMRIbecamepositiveat1or2
yearsfollowͲup.InoneHLAͲB27positivepatientofthesesixpatientstheMRIremained





Table3.2 MRI status over time according to the ASAS/OMERACTMRIworking group definition in 68





9 + + + 8
5 + + NA 4
2 + Ͳ + 2
1 + + Ͳ 0
2 + Ͳ Ͳ 0
2 + NA + 1
2 + NA Ͳ 0
1 + NA NA 1
26 Ͳ Ͳ Ͳ 6
2 Ͳ Ͳ + 0
7 Ͳ Ͳ NA 3
1 Ͳ + + 1
1 Ͳ + Ͳ 0
2 Ͳ + NA 2
5 Ͳ NA NA 3
+=positiveMRI; Ͳ=negativeMRI,ASAS=Assessment of SpondyloArthritis international Society; ESpAC=Early





wereHLAͲB27positive. In total23of these24patientscompletedeitheroneor two
followͲupMRIs.TheMRIbecamenegative insevenofthese23patients(30%)during
followͲupatoneoratbothassessments.Fiveof thesesevenpatientswereHLAͲB27
negative and in three of them theMRIwas onlyweaklypositive atbaseline. In the
80~Chapter3
remainingtwopatientsastronglypositiveMRIwasdetectedatbaseline,buttheMRI
becamenegativeduring followͲup. In twoHLAͲB27positivepatientswithanegative
MRIat1yearfollowup,theMRIwaspositiveagainat2yearsfollowͲup.
FactorsdeterminingapositiveMRI
In theGEEanalysis,bothmalegender (odds ratio (OR)3.0 (95% confidence interval
(CI); 1.1–8.2), p=0.035) and HLAͲB27 positivity (OR 5.1 (95% CI 1.9Ͳ13.6), p<0.001)
independentlydeterminedthe likelihoodofapositiveMRIatanytimepoint.CRPdid
notcontributetoexplainingvariation inthemodel.Theeffectsofthesedeterminants
are visualised in an absolutemanner in Figure 3.1, showing that the likelihood of a


















Figure3.1 Likelihood of a positiveMRI at any time point in patientswith shortͲstanding inflammatory




wasalso investigated.BothHLAͲB27 status (OR8.1 (95%CI2.3–28.3),p<0.001)and





MRIatbaseline.The likelihood iscloseto90% incaseofanHLAͲB27positivepatient















Figure3.2 Likelihood of a positiveMRI at 1Ͳ or 2Ͳyears of followͲup in patients with shortͲstanding
inflammatorybackpainassessedatbaseline,1Ͳyearand2ͲyearsoffollowͲup,infunctionofthe
result of the baseline MRI (negative or positive) and HLAͲB27 status. HLAͲB27, human
leukocyteantigenB27.
DISCUSSION








can conclude that if sacroiliitis is detected byMRI, there is a high likelihood that





In general, bothmale gender andHLAͲB27 positivity independently determined the
likelihoodofapositiveMRIatanytimepoint.This isnotsurprising,sinceSpAand in




earlySpA.However, insight intheevolution inMRIfindings inpatientswithearlySpA
andsacroiliitis is limited,since followͲupstudiesarescarce.Toourknowledge,this is
the first study in patients with early IBP with three successive MRI examinations
spanning2yearsof followͲup.Puhakkaetal.performeda1Ͳyear followͲup study to
describe changes inMRI findings of the SI joints in 34 patientswith SpA of recent





SPARCC and the Aarhus gradingmethods.[14, 15] Both systems have proven to be
reliable and reproducible. With the SPARCC scoring method, a maximum of six
consecutiveslicesareevaluated. Instead,wechose toscore theentireSI jointonall
qualitativelyoptimalslices.Thiswasdonetomaximisethedetectionofactive lesions.
In practice, it implied that in themajority of patients between 5 and 8 sliceswere
evaluated,whiletakingcarethatthesame(numberof)sliceswerescoredperpatient




limitation of themethod if the technique forobtainingoblique coronal slices is not




at both followͲup visits.Missing data may have influenced the results, since it is
possible thatpatientswithmissingMRIs representaproportionofpatients inwhom
 ActivelesionsonMRIofthesacroiliacjoints~83
the symptoms that made them eligible for inclusion in the ESpAC study have
disappeared.Althoughsuchabiascannotbeexcluded,GEEadjuststosomeextentfor
such spurious effects, by adjusting forwithinͲpatient correlation and not excluding
patientswithmissingtimepoints.Anotherlimitationofthisstudy isthattheMRIsets
were scoredbyone reader.However, the scoring systemused in thepresent study
uses a combinationof scoring systems that alreadyhaveproven tobe reliablewith
respectto interͲreaderagreement.[19]Ageneral issueregardingassessmentofMRIs
of theSI joints, is that inapreviousstudy inup to30%of theSI jointsof individuals
with chronic low back pain or healthy controls abnormalities were detected [20]
Suchlesionsmayhavecontributedtosomeextenttotheresultswehavefound,butit
is likely that these abnormalitieswill disappear in nonͲinflammatory conditions over
timeincontrasttomalepatientswithIBPthatareHLAͲB27positive.Atlast,theESpAC
cohort in which the analyses were performed is a rather small cohort with
characteristics thatdonotnecessarily resemble theaveragepatientpresentingwith
complaints suggestive of SpA. Extrapolation of findings should therefore be done
cautiously.

Inconclusion,MRI isaveryuseful imaging technique inestablishing inflammation in
theSIjointsandmaycontributetomakingadiagnosisofaxialSpAinpatientswithIBP.
InthiscohortofpatientswithIBPofrecentͲonset,itseemsthatduringa2ͲyearfollowͲ
upperiod, theproportionofpatientswithandwithout signsofMRIactivity remains
stabletoagreatextent.This isan important finding,since itsuggeststhat incaseof
bothanegativeMRIandanegativeHLAͲB27status,aclassifyingdiagnosisofaxialSpA
canbeexcludedwithgreatcertainty.Inthiscohortwefoundthatthecombinationofa
positiveMRI scan and HLAͲB27 positivity is associated with a high likelihood of a
persistentpositiveMRIduringfollowͲup. InHLAͲB27positivepatientswithanegative
MRIatbaseline, inwhomaclassifyingdiagnosisofaxialSpAcannotbemadeby the
routeofHLAͲB27presenceplus twoadditionalSpA features,a followͲupMRIcanbe




















subsequent development of sacroiliitis on plain radiograpghy. A prospective, longitudinal study. J
Rheumatol1999;26:1953Ͳ8.
9. BennettAN,McGonagleD,O'ConnorP,etal.SeverityofbaselinemagneticresonanceimagingͲevident





11. Calin A, Porta J, Fries JF, et al. Clinical history as a screening test for ankylosing spondylitis. JAMA
1977;237:2613Ͳ4.
12. HeuftͲDorenbosch LH, LandewéR,WeijersR,et al.Combining informationobtained frommagnetic
resonance imaging and conventional radiographs to detect sacroiliitis in patientswith recent onset
inflammatorybackpain.AnnRheumDis2006;65:804Ͳ8.
13. HeuftͲDorenboschL,WeijersR,LandewéR,etal.Magnetic resonance imagingchangesof sacroiliac
jointsinpatientswithrecentͲonsetinflammatorybackpain.ArthritisResTher2006;8:R11.
14. MaksymowychWP, Inman RD, Salonen D, et al. Spondyloarthritis research consortium of Canada
magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing
spondylitis.ArthritisRheum2005;53:703Ͳ9.
15. PuhakkaKB,JurikAG,EgundN,etal.Imagingofsacroiliitisinearlyseronegativespondyloarthropathy.
Assessment of abnormalities byMR in comparisonwith radiography and CT. Acta Radiol 2003;44:
218Ͳ29.
16. RudwaleitM,JurikAG,HermannKͲGA,etal.Definingactivesacroiliitisonmagneticresonanceimaging
(MRI) forclassificationofaxial spondyloarthritis:aconsensualapproachby theASAS/OMERACTMRI
group.AnnRheumDis2009;68:1520Ͳ7.
17. Puhakka KB, Jurik AG, SchiottzͲChristensen B, et al.MRI abnormalities of sacroiliac joints in early
spondyloarthropathy:a1ͲyearfollowͲupstudy.ScanJRheumatol2004;33:332Ͳ338.




20. WeberU, LambertRGW,OstergaardM, et al. The diagnosticutility ofMRI in spondyloarthritis:An






































Patientswith IBPч2yearswere followed for2yearswithannualMRIͲSIJ.MRIswere
scoredforBMEandstructuralchanges(erosionsandfatty lesions).Pelvicradiographs
were graded according to themodified New York (mNY) criteria.With generalized





the 2Ͳyear followͲup, pelvic radiograph grading remained constant. On MRI, the
numberoferosionsperpatientincreasedsignificantly(meanscore2.5atbaselineand
3.5at2ͲyearsfollowͲup;p=0.05).Atrendwasfoundforan increase inthenumberof












MRIof thesacroiliac joints (MRIͲSIJ)andpelvicradiographsplayan importantrole in
the diagnosis and classification of axial spondyloarthritis (axSpA). Both imaging
techniquesare included in the“imagingarm”of theAssessment inSpondyloArthritis
internationalSociety (ASAS)criteria foraxSpA.[1]MRIͲSIJhasespeciallyproven tobe
usefulintheearlystageofaxSpA,becauseMRImaydetectsacroiliitisyearsbeforeitis
seen on a pelvic radiograph. Moreover, MRI can detect both active lesions and
structural changes, in contrast to pelvic radiographs which only detect structural
changes.[2] Patientswithout radiographic sacroiliitis, butwith active lesions onMRI
suggestiveforsacroiliitis,arelabellednonͲradiographicaxSpA(nrͲaxSpA).[1]
Active (inflammatory) lesions thatcanbedetectedonMRIarebonemarrowedema
(BME),capsulitis,synovitisandenthesitis.StructuralchangesonMRIareerosions,fat
deposition(fattylesions),sclerosisandankylosis.[1,3]Todate,onlyBMEisconsidered
mandatory for fulfilment of the ASAS/Outcome Measures in Rheumatoid Arthritis
Clinical Trials (OMERACT) working group definition of a positiveMRI.[2] However,
Weberetal.suggestedthatalsothedetectionoferosionsonMRIͲSIJmaybehelpfulin
makingadiagnosis inearlyaxSpA.[3]There is,however, limitedknowledgeaboutthe
developmentof structural changesasdetectedonMRIͲSIJ inpatientswithearly IBP
who may possibly have or develop axSpA. Furthermore, data on the association
between BME and development of structural changes are scarce. Only one study
suggestedthatfattylesionsonMRIͲSIJmaybethefirstsignofstructuraldamageafter
previousactiveinflammation.[4]












IBP.Patientshad to fulfilat least4of thecriteria:onsetbefore theageof40years,
duration of back painmore than 3months, insidious onset,morning stiffness, and
improvementwithexercise.[8]Patientswho fulfilledonly3outof5ofCalincriteria,
but reported night pain were also included. Presence of other SpA features was
preferredbutnotobligatory.Patientswerenottreatedwithbiologicaltherapyduring
theentirestudyperiod,theuseofnonͲsteroidalantiͲinflammatorydrugs(NSAIDs)was
allowed. The study was approved by the ethics committee from the Maastricht
UniversityMedicalCenter.Allpatientsgavewritteninformedconsent.
MRIprotocol
MRIͲSIJ was performed using a 1.5 Tesla Philips Gyro scan ACSͲNT (Philips, The
Netherlands). Patients were placed in supine position in a spine surface coil. The
following sequenceswere used in an oblique coronal plane: T1Ͳweighted spin echo
(SE), short tau inversion recovery (STIR)andT2Ͳweighted fastSEwith fat saturation.




scoring system.[9,10] In contrast to the original SPARCC system, there was no
maximumtothenumberofevaluatedslices,butthenumberofsliceswithinapatient
was kept the same for all time points. First, each SIJwas divided into 4 quadrants
(upper/lower sacral and upper/lower iliac quadrant) and both BME and structural
changes were scored separately per slice in a dichotomous manner (absent vs.
present). Second, a total count of both BME and structural changes per SIJ was
performed. The method for scoring BME has been published.[11] The structural
changes scores included scoring of both erosions and fatty deposition of the bone
marrow (fatty lesions). Erosions, defined as cortical defects of the SIJ lining, are
detectedashypointensesignalontheT1sequence.Subcorticalfattylesions,definedas
replacement of normal bonemarrow by fatty tissue, are detected as an increased
signalontheT1sequence.AccordingtotheASAS/OMERACTworkinggroupdefinition













at leastgrade2bilaterallyorgrade3Ͳ4unilaterallymustbepresent for fulfillmentof
themNYcriteria.[12]
Statisticalanalysis




(8quadrantsper patient)using descriptive analysis.Generalized estimated equation
(GEE) analysis was performed to investigate a time trend in the MRI and pelvic
radiographstructuralchangesscores.GEE isamodelthatallowsstudyingtimetrends
while taking the withinͲsubject correlation into account in a dataset with missing












Baselinecharacteristicsof the68patients included inESpACareshown inTable4.1.
MRIͲSIJ and pelvic radiographs were obtained in all patients at baseline. SixtyͲtwo
(91%) patients had at least 1 followͲupMRI and 44 (65%) patients completed both
followͲupMRIs.SixtyͲfive(96%)patientshadatleast1followͲuppelvicradiographand
48 (71%) patients completed both followͲup pelvic radiographs. In 10 (15%) of 68




























The values are expressed as number (percentage) of patients unless stated otherwise. ESpAC=Early
Spondyloarthritis Clinic; SpA=spondyloarthritis; IQR=interquartile range; SD=standard deviation; CRP=CͲ
reactive protein; ESR=erythrocyte sedimentation rate; BME=bone marrow edema; MRIͲSIJ=magnetic





Atbaseline,64 (94%)outof68patients fulfilled the European Spondyloarthropathy





ASAS axSpA criteria, 9 patients fulfilled only the imaging arm, and 9 other patients




4.3 show the baseline and followͲup MRI findings for erosions and fatty lesions,









5 + + + 3 4 4
2 + + NA 1 2 2
3 + NA + 2 3 1
1 + + Ͳ 1 1 1
1 + NA NA 1 1 1
35 Ͳ Ͳ Ͳ 3 14 11
11 Ͳ Ͳ NA 1 7 6
1 Ͳ Ͳ + 1 1 1
2 Ͳ + + 1 2 0
1 Ͳ + NA 1 1 1
1 Ͳ NA Ͳ 0 1 0
5 Ͳ NA NA 0 3 3
ThenumberofpatientswithpresentorabsentsignsoferosionsonMRIͲSIJatbaselineandduringfollowͲup
isshown. aNumberofpatients that fulfil themNYcriteriaatbaseline. bNumberofpatients that fulfil the
ASAS axSpA criteria at baseline. c Number of patients that are HLAͲB27 positive. +=structural changes
present; Ͳ=structural changes absent,NA=MRI not available,MRIͲSIJ=magnetic resonance imaging of the

















6 + + + 3 5 5
2 + + NA 1 2 2
1 + NA + 1 1 0
1 + NA Ͳ 0 1 0
2 + Ͳ + 1 2 1
1 + NA NA 1 1 1
35 Ͳ Ͳ Ͳ 4 14 11
9 Ͳ Ͳ NA 1 5 4
1 Ͳ NA Ͳ 0 1 0
1 Ͳ + + 1 1 0
3 Ͳ + NA 1 3 3
1 Ͳ NA + 1 1 1
5 Ͳ NA NA 0 3 3
ThenumberofpatientswithpresentorabsentsignsoffattylesionsonMRIͲSIJatbaselineandduringfollowͲ
upisshown.aNumberofpatientsthatfulfilthemNYcriteriaatbaseline.bNumberofpatientsthatfulfilthe
ASAS axSpA criteria at baseline. c Number of patients that are HLAͲB27 positive. +=structural changes
present; Ͳ=structural changes absent,NA=MRI not available,MRIͲSIJ=magnetic resonance imaging of the







of these4patients, theerosionswereaccompaniedby simultaneousappearanceof
fattylesionsonMRI.Five(10%)outof50patientswithoutfattylesionsatbaselineand
at least1 followͲupMRIdeveloped fatty lesionsduring followͲup, fourof themwere
HLAͲB27positiveand3patientsfulfilledthemNYcriteriaatbaseline(Table4.3).
In1 (8%)outof12patientswitherosionsonMRIatbaseline, theerosionswerenot




Atbaseline,15 (22%)patients fulfilled themNYcriteria forradiographicsacroiliitisof
which80%wereHLAͲB27positive.Eight (53%)of these15patientsalsohadBMEat
baselineand in9 (60%)patientserosionsand/or fatty lesionsweredetectedonMRI.






The firstanalysiswasaGEEanalysis (scoresof58patientswithat least2successive

























order to investigate the association between the presence of BME and the
developmentoferosionsand/orfatty lesionsatthesamesite.Thisanalysiswasdone





analysis which are presented in Table 4.5 show that an increase of fatty lesions
































Allquadrants 89 47 14(30) 42 11(26)




The present study has demonstrated that BME on MRIͲSIJ is associated with the
developmentoffattylesionsinacohortofpatientswithearlyIBP.Suchanassociation
could not be demonstrated for erosions, despite a significant overall numerical
increase of erosions over time. Furthermore, approximately 10% of the patients
without erosions and fatty lesions atbaseline developed new structural changes on
MRIduringthe2ͲyearfollowͲupperiod.
An increase in the number of structural changes on MRI over time has been
demonstrated in a previous study evaluatingMRIͲSIJ abnormalities in patientswith
earlyaxSpA.[13]InthisstudybyMadsenetal.80outof94(85%)patientswithaxSpA
had erosions and fatty lesions present onMRI at baseline. After amean followͲup
periodof51months,both thenumberoferosionsand fatty lesionshadsignificantly
increased.[13]Wehavealsofoundasignificantincreaseinthenumberoferosions,as
wellasastrong trend foran increase in thenumberof fatty lesions. In thestudyby
Madsen et al., the proportion of patients with structural changes was higher at
baselinecomparedwithourcohort(85%versus25%),andalsotheirfollowͲupduration
was longer,whichmightexplainthedifference intimetrends found for fatty lesions.
Thepresenceoffattylesionsmightalsobeunderestimatedinourstudyduetothefact
that thepresenceof intenseBMEmayprevent thedetectionof fatty lesionsdue to
counteractingMR signals on the T1MRI sequence (BME low signal intensity; fatty
lesionshighsignalintensity).[4]
 StructuralchangesonMRIofthesacroiliacjoints~95













was significantly higher at vertebral cornerswith BME at baseline as compared to
vertebral cornerswithout BME at baseline (18% vs. 3%).[14] A correlation between
BME and the subsequent development of fatty lesions on MRIͲSIJ could not be
demonstrated in the SPondyloArthritis Caught Early (SPACE)Ͳcohort over a 3Ͳmonth
followͲup period.[15] This last finding suggests that a longer followͲup period is
necessarybeforefattylesionscanbedetectedinresponsetosubsidingBME.
Whilstwehave foundan increase in thenumberoferosions in this study,wehave
failedtodemonstrateasignificantassociationbetweenthepresenceofBMEandthe
development of erosions. A possible explanation is that the erosions occur
independently of inflammation. Larger cohorts are necessary to provide sufficient





increases to around 20% per 2 years.[17] Our study has failed to demonstrate an
associationbetweenBMEanddevelopmentofstructuralchangesdetectedonpelvic
radiographs,norcouldwedemonstrateachangeinthelevelofsacroiliitisaccordingto









accurate image interpretation.Thenatural irregularshapeofthecortical liningofthe
SIJmayalso limitdetectionoferosions. Inthepresentstudy,ofthe15patientswith
sacroiliitis on pelvic radiographs according to independent readers, erosions and/or
fattylesionsonMRIweredetectedinonly9(60%)patientsatbaseline.Themajorityof
thepatients,whodevelopednewerosionsand/or fatty lesionsonMRIduring followͲ
up,alreadyfulfilledthemNYcriteriaatbaseline.
Some limitations of the present study need to be addressed. First, theMRIswere
scoredbyone readeronly,whichmay in theory influence the reliabilityof thedata.
However, the reader was very experienced and the MRI scores showed a high
consistencyovertimedespitescoringeachMRIset independentlyandblindingofthe
reader for timeorder. Furthermore, and in contrast to scoringpelvic radiographs,a
numberof studieshaveshownaratherhigh interͲobserveragreementwhenscoring
MRIͲSIJs.[9,20] Second, in the present study, the T1 and STIR sequence were
simultaneously scored foractive lesionsand structuralchanges.This scoringmethod
couldhave resulted in readerbias,since thepresenceofBMEon theSTIRsequence
maypossiblyhavetriggeredthereadertoscreenmorecarefullyforstructuralchanges
on the T1 sequence or vice versa. This may influence the sensitivity for scoring
structural changes onMRIͲSIJ. In 16 of the 17 patients with erosions and/or fatty
lesions at baseline, concomitant BME was also found. However, one could also
postulatethatconcomitantBMEdecreasesthespecificityofscoringstructuralchanges
onMRI,sinceareader ismore likely toscorean indeterminate lesionasastructural
change.ScoringtheT1andSTIRsequenceindependentlycouldpossiblylowertherisk
ofreaderbiaswhenevaluatingthepresenceofactivelesionsandstructuralchangeson
MRIͲSIJ. Third, in theMRI scoring system used in the present study,we applied an
unlimitednumberofevaluatedslices.Serial imageacquisitionofthesameanatomical
regionoffersadvantagestomonitorchangesovertime.However,thisscoringmethod
may be limited by the possibility of misalignment between 2 successive MRI
examinations,whichmay causemeasurementerror. Last,ESpAC isa relatively small
cohortwith selectedpatients.Patientswere referredby (related)medical specialties
(i.e. dermatology, gastroenterology) and through family members of the local
ankylosing spondylitis society. This referral strategy may explain the relative high
proportionofpatientswithextraͲaxialmanifestationsand/orpositivefamilyhistoryfor





that includedpatientswithearly IBP.[21,22]Nevertheless,extrapolationof thestudy
findingsshouldbedonewithcaution.
In conclusion, in this cohort of patients presenting with IBP of recent onset and
suspectedforaxSpA,thenumberofpatientswitherosionsandfatty lesionsdetected
onMRIͲSIJremained relativelystableduring the2yearsof followͲup,but theoverall
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To evaluate the potential incremental value in detecting sacroiliitis of the T1 postͲ
gadolinium diethylenetriaminepentaacetic acid (GdͲDTPA) MRI sequence of the
sacroiliac joints (SIJ) comparedwith the combinationof short tau inversion recovery




A 2Ͳyear followͲup study was conducted in patients with IBP of less than 2 years
duration.AnnualMRIoftheSIJ(MRIͲSIJ)wasperformedandscoredforbonemarrow
edema (BME). Pelvic radiographswere scored according to themodifiedNew York
(mNY)criteria.AgreementonthepresenceofBMEdetectedbytheSTIRandpostͲGdͲ








SixtyͲtwo (91%) patients had at least 1 followͲup MRIͲSIJ. At 2Ͳyear followͲup,









Pelvic radiographs and magnetic resonance imaging (MRI) are important imaging
techniques todetect sacroiliitis inpatientswitha suspicionofaxial spondyloarthritis
(axSpA). In the Assessment in SpondyloArthritis international Society (ASAS) axSpA
classificationcriteria,sacroiliitisoneitherMRIorpelvicradiographisusedastheentry
criterion for fulfillment of the ‘imaging arm’.[1].WithMRI, both active lesions and
structuralchangescanbedetected,incontrasttopelvicradiographsthatonlyvisualize
structuralchanges.Typical‘active lesions’ inthesacroiliacjoints(SIJ)detectedbyMRI
are subchondral bone marrow edema (BME), as well as synovitis, enthesitis and
capsulitis.[2]DifferentMRItechniquescanbeusedtodetectactive lesions;theseare
short tau inversion recovery (STIR) thatsuppresses thesignal intensityof fat,andT1
withorwithoutfatsuppressionafteradministrationofthecontrastagentgadolinium
diethylenetriaminepentaaceticacid(GdͲDTPA).OnlyBMEontheSTIRorpostͲGdͲDTPA
sequence is considered for the definition of active sacroiliitis according to the
ASAS/Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT)
consensus.[2] The ASAS/OMERACTMRI working group further states that the STIR
sequencealoneisusuallysufficienttodetectsacroiliitis.Thisstatementissupportedby
several studies that found no additional value of the postͲGdͲDTPA sequence
compared with the STIR sequence in detecting sacroiliitis in patients with early or
established axSpA.[3,4] However, these studies were crossͲsectional[3] or had a






value isovera longer followͲupperiod,especially inpatientswithearlydisease,and
takingthepelvicradiograph intoaccount.FluctuatingorsubsidingBMEoneitherthe





DTPAsequence fordetecting sacroiliitiscomparedwith thecombinationofSTIRMRI
sequence and pelvic radiographs in patients presenting with IBP of short duration
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Patients with IBP of less than 2 years duration were enrolled in the Early
SpondyloArthritis Clinic (ESpAC) study. In this prospective cohort study, systematic
clinical and radiological examinations were performed at baseline and after 1 and
2years. A more detailed description of the study population has been reported
previously.[7] For IBP tobepresent,patientshad to fulfil4of the following5Calin
criteria:onsetof symptomsbefore theageof40 years,durationofbackpainmore
than3months, insidiousonset,morningstiffnessand improvementwithexercise.[8]
Patientswhofulfilledonly3outof5oftheCalincriteriabutreportednightpain,were
also eligible. Presence of extraͲaxial manifestations of SpA was preferred but not
obligatory.Patientswerenot treatedwithbiological therapyduring theentire study









x T1Ͳweighted SE with fat suppression after administration of the intravenous
contrastagentGdͲDTPA(0.1mmol/kgbodyweight),512x256matrix
The slice thicknesswas4mmwith0.4mm intervals.EachMRI setwas scoredwith




TheMR imageswere scored using a combination of the Spondyloarthritis Research
Consortium of Canada (SPARCC)method and amodified version of theAarhusMRI
scoring method.[9,10] In contrast to the original SPARCC system, there was no
maximum to the number of evaluated slices, in order tomaximise the detection of
abnormalMRIfindings.Thenumberofevaluatedsliceswithinaindividualpatientwas
kept the same forall timepoints.EachSIJwasdivided into4quadrants:upper iliac,
lower iliac, upper sacral and lower sacral.All images (STIR and postͲGdͲDTPA)were
scored for the presence of subchondral BME with the corresponding T1 sequence
withoutcontrastsimultaneously.BMEpresentinthecartilaginouspartofthejointwas
scoredper slice inadichotomousmanner (present vs.absent).BMEwasdefinedas
areas of increased signal intensity on both the STIR and postͲGdͲDTPA images
comparedwithnormalbonemarrow,and itspresencewasestimated ineachof the
4quadrants.Sincesynovitis,capsulitisandenthesitisarenotconsideredsufficient for
thedefinitionofapositiveMRIaccording to theASAS/OMERACTdefinition,only the
MRIscoresofBMEweretakenintoaccount.[2]




Anteroposterior pelvic radiographs of the SIJ were obtained from all patients at
baselineandduringoneͲ and2Ͳyear followup. Two readers (AT andRL),whowere
blinded to the clinical and laboratory findings and were not involved in the MRI
reading,independentlyscoredallradiographswithunknowntimesequenceaccording
to themodifiedNewYork (mNY)criteria.[11] Incaseofdisagreement, judgmentofa
thirdreader(DH)wasconclusive.
Statisticalanalysis
Descriptive statistics were used to analyse the presence of BME on MRIͲSIJ and
structuralchangesonpelvic radiographsatbaselineandduring the2Ͳyear followͲup
period.AgreementonthepresenceofBMEsuggestiveforsacroiliitisdetectedbySTIR
andpostͲGdͲDTPAsequenceswasanalyzedonaperpatientbasisbykappastatistics.A
kappavalueof0Ͳ0.20 indicatedpooragreement,0.21Ͳ0.40 indicated fairagreement,













Atbaseline,64 (94%)outof68patients fulfilled the European Spondyloarthropathy
Study Group (ESSG) and/or Amor and/or ASAS axSpA classification criteria. Fifteen
(22%)patientsfulfilledthemNYcriteriaatbaselineandin24(35%)patientsBMEwas






BMEwas detected on the STIR sequence only, but thiswasminimal in 3 of these
4patients.NoneofthepatientshadsignsofBMEonthepostͲGdͲDTPAsequenceonly.
TwentyͲthree (96%) of 24 patientswith BME onMRI at baseline had at least one
followͲupMRI.Amoderate togoodagreementbetween theSTIRandpostͲGdͲDTPA





























The values are expressed as number (percentage) of patients unless stated otherwise. ESpAC=Early
Spondyloarthritis Clinic; SpA=spondyloarthritis; IQR=interquartile range; SD=standard deviation; CRP=
CͲreactive protein; ESR=erythrocyte sedimentation rate; BME = bone marrow edema; MRI=magnetic
resonance imaging; ESSG=European Spondyloarthropathy Study Group; ASAS=Assessment in SpondyloͲ












Five (13%)of39patientswithout signsofBMEonboth theSTIRandpostͲGdͲDTPA
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DTPA sequence only at baseline. Thirty (97%) of 31 patients had both at least one
followͲupMRIͲSIJandat leastone followuppelvic radiograph.At followͲup,nonew




The present study showed that the postͲGdͲDTPAMRI sequence does not have an
incrementalvalue inthedetectionofsacroiliitis inacohortofpatientswithearly IBP
whowerefollowedfor2yearscomparedtothecombinationofSTIRMRIsequenceand
pelvicradiographs.
BothMRI sequences can be used to detect sacroiliitiswith similar efficiency, as is
reflectedinthehighkappavaluesfoundinourstudy.Earlierstudiesalsocomparedthe
concordance between STIR and postͲGdͲDTPA sequences in detecting BME on
MRIͲSIJ.[3,4]DeHooge et al. found a 100% agreementbetween the STIR and postͲ
GdͲDTPAMRIsequence indetectingBMEonMRIͲSIJ inaprospectivecohortstudyof
127patientswith chronic back pain of less than 2 years durationwith onset below
 ValueofGadoliniumcontrastͲenhancedMRIsequence~109
45years.[4].In8(6%)ofthe127patients,synovitisand/orcapsulitisand/orenthesitis












period. In a small subset of patients, BME could be detected on the postͲGdͲDTPA
sequence only during followͲup. However, these patients already fulfilled themNY
criteria. This suggests that postͲGdͲDTPA sequence does not provide additional
diagnostic information in the detection of sacroiliitis in this cohort of patientswith
early IBP when information from the STIR sequence and pelvic radiographs are
combined.
The present study shows that in case of discordance between the STIR and postͲ
GdͲDTPA sequences,BMEwasmainlydetectedon the STIR sequence. In aprevious
study in the same cohortwehavedemonstrated that the combinationofapositive
MRIscanforBMEandapositiveHLAͲB27statusisassociatedwithahighlikelihoodof
persistent signs of BME onMRI during followͲup.[13] Five patients in our cohort
showed subsiding BME on the STIR sequence without BME on the postͲGdͲDTPA
sequence during followͲup, and all of themwereHLAͲB27 negative. Three of these
5patientsdidnot fulfil themNY criteria.Whether theMRI in these5patients gave




Aarhus gradingmethod.[9,10]Both scoring systemshaveproved tobe reliablewith
respecttointerͲreaderagreement.[14]IncontrasttotheSPARCCmethod,weapplied
anunlimitednumberofslicestobeevaluated,andthesame(numberof)sliceswere
scoredperMRIexaminationperpatientover time.Theadvantageof thismethod is
that all qualitatively optimal slices are scored, thereby maximising the chance of
110~Chapter5
detecting active lesions. A general concern when scoring MRIs of the SIJs is the
possibility of misalignment between two successiveMRI examinations, which may




scored by one reader. However, the reader was experienced and theMRI scores
showedhighconsistencyovertimedespite independentscoringofeachMRIsetand
blinding of the reader for time order. Second, the STIR sequence was not scored
independentlyofthepostͲGdͲDTPAsequence.Thismighthavecontributedtothehigh
perpatientkappavaluesatbaselineandfollowͲup.Third,anumberofMRIsandpelvic
radiographs was missing at followͲup. Baseline MRIs and pelvic radiographs were
neverthelesscompleteandthebaselineresultsalready ledtotheconclusionthatthe




presence ofBME on the STIR sequence.[15] Fifth, in ESpAC, theuseofNSAIDswas
allowed. The actual use ofNSAIDs per patientwas not recorded. It is possible that
continuousoronͲdemandtreatmentwithNSAIDsmayhaveledtosubsidingBME.[16]
However, a number of BME lesions may also have subsided due to the natural
fluctuatingcourseofthedisease.[17]Last,patients included inESpACwererecruited
via local rheumatologists, (related) medical specialties (i.e. dermatology,
gastroenterology) and through family members of the local ankylosing spondylitis
society.Thisselectiverecruitmentmayexplaintherelativehighproportionofpatients
that fulfilled a least one of the classification criteria for axSpA. Furthermore, the
proportionoffemalepatientsinESpACisrelativelyhigh(62%)whereastheproportion
of patients with a positive HLAͲB27 status is relatively low (46%). However, these
percentages are in accordancewith other cohorts that included patientswith early
IBP.[18,19]Nevertheless,extrapolationofthestudyfindingsshouldbedonecautiously.
In conclusion, combined use of pelvic radiographs and the STIR MRI sequence is
sufficient for detecting sacroiliitis in this early IBP cohort suspected for axSpA. The
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Atbaseline,68patients (38%male;meanage34.9±10.3 years)were included.BME
was visible at baseline in 24 (35%) patients, all fulfilling the ASAS axSpA criteria.
TwentyͲthreeof these24patientshada followͲupMRI.Not taking intoaccount the
baselineMRI, 3 (13%) of these 23 patientswould no longer fulfill theASAS criteria
during followͲupbecauseofsubsidingBME.FortyͲfour (65%)patientshadanegative
baselineMRI, of whom 39 have a followͲupMRI available. New BME at followͲup
meant that3 (8%)of these39patientsnow fulfilled theASAS criteria.At followͲup,




BME showsa fluctuating course inpatientswithearly IBP suspected foraxSpA.This




Inflammation of the sacroiliac joints (SIJ) detected onmagnetic resonance imaging
(MRI)isacommonfindinginaxialspondyloarthritis(axSpA).[1]Indailypractice,MRIis







To date, there is limited knowledge about the exact distribution, frequency of
occurrence, and evolution over time of BME detected onMRI of the SIJ (MRIͲSIJ),
especially in patients with short duration of disease. Knowledge about the natural
courseofBMEisimportantbothforresearchanddailypractice.MRIisfrequentlyused
asan“objective”measureofoutcometoexaminetheefficacyof(biological)therapyin
clinical trials.However,as anexample, subsiding lesionsmay give the impressionof
efficacyoftreatment,whereasthismayinfactbethenaturalcourse.Also,fluctuating
or subsiding BME may affect the sensitivity and specificity of MRI in detecting
sacroiliitis,whichmayhamperthediagnosticprocess.




Patients with IBP of less than 2 years duration were enrolled in the Early
SpondyloArthritis Clinic (ESpAC) study. In this prospective cohort study, systematic
clinical and radiologicalexaminationswereperformed atbaseline and after1and2
years. A more detailed description of the study population has been reported
previously.[3]For IBPtobepresent,patientshadtofulfilat least4ofthefollowing5
Calin criteria:onsetof symptomsbefore the ageof40 years,durationofbackpain






Fulfilment of the ASAS axSpA criteria [2], modified New York (mNY) criteria [5],
EuropeanSpondyloarthropathyStudyGroup (ESSG)criteria [6],andAmorcriteria [7]




TheMR imageswere scored using a combination of the Spondyloarthritis Research
Consortium of Canada (SPARCC)method and amodified version of theAarhusMRI
scoringmethod.[8,9]IncontrasttotheoriginalSPARCCscoringmethod,therewasno
maximumtothenumberofevaluatedslices,butthenumberofsliceswithinapatient
was kept the same for all time points.MRIswere scored as series per patientwith
unknown timesequencebyanexperiencedreader for thepresenceofbonemarrow
edema (BME) on the Short Tau Inversion Recovery (STIR) sequence. Each SIJ was
dividedinto4quadrantsandthepresenceofBMEwasrecordedforeachSIJͲquadrant.
The ASAS/OMERACT definition was followed for fulfilment of a positive MRI for









MRIͲSIJ for fulfilment of the ASAS axSpA criteria at baseline and at followͲup.[2]








all included patients. SixtyͲtwo (91%) patients had at least 1 followͲupMRI and 44
(65%)patientscompletedbothfollowͲupMRIs.SixtyͲfive(96%)patientshadatleast1





























The values are expressed as number (percentage) of patients unless stated otherwise. ESpAC=Early
Spondyloarthritis Clinic; SpA=spondyloarthritis; IQR=interquartile range; SD=standard deviation; CRP=CͲ
reactiveprotein;ESR=erythrocytesedimentationrate;BME=bonemarrowedema;MRI=magneticresonance





SixtyͲsix (97%) patients fulfilled the Calin criteria at baseline. The remaining 2 (3%)
patientsfulfilled3ofthe5Calincriteriaandreported‘nightpain’.Atbaseline,40(59%)
outof68patients fulfilledtheASASaxSpAcriteria.TwentyͲtwopatients fulfilledboth
the imaging and clinicalarmof theASAS axSpA criteria;9patientsonly fulfilled the
imagingarmand9patientsonlyfulfilledtheclinicalarm.Atbaseline,58(85%)patients








WĞƌ ^/:ͲƋƵĂĚƌĂŶƚ. Table 2 shows that in all four quadrants of the SIJ,BME could be
detectedonMRI.Therightcaudal iliacquadrantoftheSIJwasslightlymoreaffected





at the last followͲup in 62 patients with at least one followͲup MRI and pelvic





were HLAͲB27 negative, and because BME onMRI also completely subsided, these
patientswould Ͳwithoutprior knowledgeof thebaselineMRI Ͳnot longer fulfil the
ASASaxSpA criteriaat the last available followͲupexamination.All these3patients,
however, still fulfilled the ESSG and Amor classification criteria because of various








































































WĞƌ ^/:ͲƋƵĂĚƌĂŶƚ. Table 6.2 shows that BME remained present in 53% of the SIJͲ
quadrants(range29%to69%)atfollowͲupandwaspersistentmostfrequently inthe
rightandleftcaudaliliacquadrants(table2).BMEsubsidedin47%oftheSIͲquadrants

























n=62 patients.* FollowͲup at 1 or 2 years, depending on lastMRI. The values are expressed as number




The present study, in a cohort of patients with early IBP suspected for axSpA,
demonstratedthatBMEsubsidedcompletelyinapproximatelyhalfoftheSIͲquadrants
during followͲup and in 30% of the patientswith a positiveMRIͲSIJ at baseline.On
average,inlessthan10%oftheSIͲquadrants,BMEwasnewlydetectedatsomepoint
intimeduringfollowͲup.NottakingintoaccountthebaselineMRI,13%ofthepatients
wouldnot fulfil theASASaxSpAcriteriaata followͲupmoment,asaconsequenceof




suspected on clinical grounds and conventional pelvic radiographs are normal or
inconclusive.Inthiscontext,subsidingorfluctuatingBMEmayaffectthesensitivityof
MRI indetecting sacroiliitisandsubsequentlycouldcauseadelay in thediagnosisof
axSpA.Inaddition,forclinicaltrialsitisimportanttobeawareofthefluctuatingcourse
of BME onMRI,whichmay in fact be the natural course instead of any treatment











not only evaluated the presence of BME per SIJͲquadrant over a 2Ͳyear followͲup





Some MRI studies reported that the caudal parts of the SIJ are more frequently




quadrants is rather equallydistributed, although there is a slightpreference for the
caudaliliacSIͲquadrants,observedbothatbaselineandatfollowͲup.Thiscorresponds
withastudybyAlthoffetal.,inwhichnodifferenceintheamountofBMEbetweenSIͲ
quadrants was detected in patients with axSpA with a symptom duration of ч 5
years.[17]
It is known that approximately one third of the patients with axSpA according to
expertsdonot fulfilthe imagingarmoftheASASaxSpAcriteria.[2,18]Several factors
mightcontributetothisrestrictedsensitivityoftheimagingarm.First,MRIofthespine
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isnot included inthe imagingarmoftheASASaxSpAcriteria.However,upto70%of
thepatientswithaxSpAmayhavespinal inflammation,even intheabsenceofactive
lesionsonMRIoftheSIJs.[18]Second,structuralchanges(i.e.erosions)onMRIarenot
considered for thedefinitionofapositiveMRIͲSIJ.[2]Recentdata,however, suggest
thatassessmentoferosionsonMRIͲSIJmayenhance thediagnosticutilityofMRI in
earlyaxSpA.[19]Finally,althoughMRImightbethemostsensitiveimagingmodalityfor
detection of SIJ inflammation, not all inflammation is captured byMRI.A study has
shownthat inbiopsiestaken fromtheSIJclear inflammationonhistologywas found,
whereasthiswasnotvisibleontheconcurrentlyperformedMRI.[20]
There are several limitations of this study thatneed tobe addressed. First, theMR
imageswerescoredbyonereaderonlyforreasonsofexperiencedreaderavailability,
whichmay in theory influence the reliability of the data. However, this reader (a
musculoskeletal radiologist,andmemberof theASAS/OMERACTMRIworkinggroup)
was highly experienced, theMRIs were scored with unknown time sequence, and
blinding was preserved for clinical and laboratory findings.[1] The intraͲobserver
agreementofourreaderwasverygoodinanotherstudythatevaluatedBMEonMRIͲ
SIJs in patientswith early axial spondyloarthritis, using the Danish (Aarhus) scoring
method(weightedkappavalue0.96(95%Ͳconfidenceinterval:0.92Ͳ0.98)).[21]Further,
a high interͲobserver agreement among experienced readers for scoring ofMRIͲSIJs
has been reported in previous studies.[8,22] These arguments reasonably justify an
unbiasedacquisitionofMRIͲscores.
Second,theintervalbetween2MRIexaminationswas1year.SerialMRIexaminations
at for instance3Ͳor6months followͲupcouldprovidemore informationaboutshort














notbe studied. It is thereforeunclearwhether continuousoronͲdemand treatment
with NSAIDsmay ultimately have led to subsiding inflammation detected onMRI.
Results from the secondpartof the InfliximabasFirst LineTherapy inPatientswith
EarlyActiveSpondyloarthritisTrial(INFAST)suggestthatitmaynotbedifferent.Inthis




axSpA.However,40 (59%)patients fulfilled theASAS axSpA criteria atbaseline. The
overall sensitivity and specificity of the ASAS axSpA criteria is 82.9% and 84.4%,
respectively.Thediagnosticperformanceof theASASaxSpAcriteria isgood,withan
overall postͲtest probability of 89%.[2] Considering the characteristics of the ASAS
axSpAcriteriaand thecaveats related to thediagnosticutilityofMRI inaxSpA,most
patients included in the ESpAC that fulfil theASAS axSpA criteria,will probably also
haveordevelopaclinicaldiagnosisofaxSpA.Unfortunately,patientswerenotactively
followed after the studywas terminated. Finally, ESpAC is a relatively small cohort
including patients referred by (related) medical specialties (i.e. dermatology,
gastroenterology)andrelativesofmembersofthelocalankylosingspondylitissociety.
This recruitment strategy may therefore explain the high proportion of patients
fulfillingat leastoneoftheclassificationcriteriaforSpA.Furthermore,theproportion
ofmalepatientsinESpACisrelativelylow(38%)andtheproportionofpatientswitha
negativeHLAͲB27 status is relativelyhigh (54%).However, thesepercentages are in
accordance with other cohorts that included patients with early IBP suspected for
axSpA (24,25). IntheSPondyloArthritisCaughtEarly (SPACE)Ͳcohort, forexample,the
proportion of male patients among axSpA patients is 48%, and the proportion of
patients with a negative HLAͲB7 status is 20%.[24] In the Devenir des




iliac quadrants. Nearly half of the BME lesions subsided during followͲup. These
changes inMRI status are important and should be taken into account in clinical
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A qualitative study involving semiͲstructured interviews with GPs was conducted.
Transcripts of the interviewswere independently read and annotated by 2 readers.
















GPs are aware of “classic”, but longͲterm features of axSpA. Knowledge about the
diseasespectrumandearlydetection is,however, limited.Addressingthese issues in
trainingprogrammesmay improvebetter recognitionofaxSpA inprimary care. This







SpA in Caucasian populations is approximately 1%, similarly to that of rheumatoid
arthritis.[1] Symptom patterns and physical signs of SpA can be divided into
predominantly axial involvement, with inflammatory back pain (IBP) as the most
important clinical feature and predominantly peripheral involvement including
peripheralarthritis,dactylitisandenthesitis.[2]ExtraͲarticularmanifestationsrelatedto
axial and peripheral SpA include psoriasis, anterior uveitis and inflammatory bowel
disease.
Axial SpA (axSpA) comprises a disease continuum, including both nonͲradiographic
axSpA and ankylosing spondylitis (AS).[3] Patientswith nonͲradiographic axSpA have




by general practitioners (GPs) or other referring physicians.[5] Offering tools for
referral may be helpful in improving early diagnosis. Several initiatives have been
performedtostudytheeffectofreferralstrategies inprimarycare.Theobjectivesof
these referralprogramswere to identifypatientswithpossible axSpAearly,make a
correct diagnosis, and to provide the best possible care as early as possible.[6]
However, limited knowledge of manifestations belonging to axSpA might prevent
successfulimplementationofthesereferralstrategiesintheprimarycaresetting.





For this qualitative study, GPs, acquainted with the interviewers, without known
specific interestor knowledgeofmusculoskeletaldiseasesandwith various yearsof
experience,wereinvitedforasemiͲstructuredinterview.AsemiͲstructuredinterviewis
a technique tocollectqualitativedataabout thetopicof interestbycombiningopen
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questionswiththeoptiontofurtherexploreparticularanswers.[7]Thedurationofone






An interview guide that consisted of both openͲ and closedͲended questions was
developed to secure uniform data quality and comparability. A pilot interviewwas
conductedtoensurethatthequestionswereclearandaddressedallimportanttopics.
Each interviewwasaudioͲtapedandafterwards fully transcribed.Each transcriptwas
offeredtothematchingGPtoreviewforvalidation.
Thetopicsaddressedintheinterviewincluded:
x General questions: age, working experience in years as a GP, specificmedical
interests.
x Approach to patients presenting with chronic back pain, knowledge about
symptoms indicativeofmechanicalbackpain(MBP)or IBP,managementofback
pain,motivatingfactorstoreferapatienttoarheumatologist.




x Awareness about treatment options and opinion of GPs about the current
standardsofcareforpatientswithaxSpA.
Dataanalysis
The transcripts were independently analyzed by 2 readers. All transcripts were
repeatedly read and annotated. A coding system based on the grounded theory








Ten of 16 invitedGPs agreed to participate andwere interviewed.All includedGPs
weremenandthemeanagewas49years(range37Ͳ58years;standarddeviation(SD)
6.4years).ThemeannumberofyearsofexperienceasaGPwas20years(range10Ͳ29
years; SD 6.0 years). ThreeGPs had a specific interest inmusculoskeletal disorders.
WhenGPswereaskedtoestimatethemeannumberofpatientswithASregisteredin






FourGPswerenot familiarwiththetermsMBPand IBP (quote1).SixGPsknewthat
there isadifferencebetweenMBPand IBP,buttheseGPscouldrecallonlya limited
number of typical parameters to differentiateMBP from IBP. Four of these 6 GPs
mentionedawakeningnightpainasatypicalfeatureofIBPandconsidereditarelevant
symptomthatneededattention(quote2).TwoGPsalsomentionedinsidiousonsetof





















































Two GPs considered peripheral arthritis as belonging to the spectrum of axSpA;
dactylitisandenthesitiswerenotmentionedatall.WhenaskedaboutextraͲarticular





None of the GPswould order a Human Leukocyte Antigen (HLA)ͲB27 test when a
patientpresentswithchronicbackpain.A fewGPscommented that this testshould
only be orderedby the rheumatologist (quote 5).MostGPs specifically commented
thattheywouldonlyorderaconventionalradiographincaseofchronicbackpain.One
GPmentionedthatanormalpelvicradiograph inapatientpresentingwithbackpain,




themost important treatment goals by themajority of the GPs. The use of nonͲ
steroidalͲantiͲinflammatory drugs (NSAIDs)were considered an adequate treatment
optionbyallGPs.MostGPsalsomentionedphysicaltherapyorthatthepatientshould




Most GPs expressed that (practical) referral parameters to decrease the delay in
diagnosiswouldbeusefulinclinicalpractice(quote7).MostGPsalsowantedtoknow
moreaboutthetreatmentoptions,includingantiͲTNFͲalphatherapy.OneGPrevealed








thatthere isasubstantialdelay indiagnosis.GPsalsoknewthatthere isadifference
betweenMBPandIBP,butwereunabletoexplainhowtodifferentiateMBPfromIBP.
Knowledge about the disease spectrum of axSpA and associated extraͲarticular
manifestationswas limited.AllGPswereawareof thebenefitsofphysiotherapyand
NSAIDs, and half of theGPs knew that antiͲTNFͲalpha therapy can be prescribed in
patientswithaxSpA.
Chronicbackpainisacommonsymptominthegeneralpopulationanditisestimated
that in5%ofthesecasesaxSpA istheunderlyingdisease.[8] Inapproximately75%of
thepatientswithaxSpA,thechronicbackpainhasaninflammatorycharacter.Several
criteria sets to define IBP have been proposed, consisting of several parameters in
ordertodifferentiateIBPfromMBP.Singleparameterswereinsufficientlypredictivein
defining IBP, because they are also frequently present in patients without an
inflammatory cause of their back pain.[9] Overall, the IBP criteria sets have a
comparablesensitivityandspecificityofabout75Ͳ80%.[9Ͳ11]IBPhasbeentestedasa
single referral parameter and as part of a composite referral strategy in several
studies.[5,12Ͳ14]WhenpatientswerereferredbyGPsbecauseofIBPalone,axSpAwas
diagnosed in16Ͳ33%ofthereferredpatients.[5,12Ͳ13]However,whenpatientswere
referred because of IBP in combinationwith other parameters such as HLAͲB27 or
sacroiliitis on imaging, axSpA was diagnosed in 35Ͳ56% of the referred
patients.[5,12,14]
Knowledgeof important featuresassociatedwithaxSpA isessentialbeforea referral
strategy can successfullybe implemented in theprimarycare setting.SixGPs inour
studycouldrecallonlyafew items indicativeof IBPand4GPswerenotfamiliarwith
thetermsMBPandIBP.ThiswasalsoobservedinastudybyJoisetal.[15]Only5%of
GPs in their study could identify allparameters indicativeof IBPwhen a listofpreͲ
specifiedresponsechoiceswaspresentedtothem.Furthermore,recentstudieshave
shownthatthedegreeofagreementbetweenreferringphysicians(includingGPs)and
rheumatologistswhenevaluating IBP inpatientswithsuspectedaxSpA ispoor(kappa
valuesbetween0.04–0.20).[5,16]EducatingGPsaboutthe fullrangeofparameters
indicativeofIBPthereforeseemsthefirststepbeforeIBPcansuccessfullybeusedina
referral tool. The term “axial spondyloarthritis” will also increasingly be used in
correspondence from rheumatologists toGPs. It is therefore important tomakeGPs
alsofamiliarwiththisnewterminology.
In the present study, GPs could recall only a limited number of extraͲarticular
manifestations associated with axSpA. In a some cases, GPs mentioned “eye
complaints”or“skinproblems”.Dactylitisandenthesitiswerenotatallmentionedby
 GPrecognitionofSpA~137
the GPs in our study. Jois et al. also investigated the recognition of extraͲarticular
manifestations of SpA byGPs.[15] Psoriasis, inflammatory bowel disease and uveitis
wererecognizedasanextraͲarticularmanifestationbyrespectively96%,68%and60%
ofGPs,whichisahigherproportionthaninoursmallͲsizedstudy.[15]However,inour
study openͲended questionswere used,which probably resulted in lower response
ratesthanthesurveyused inthestudyofJoisetal.AllGPs inthepresentstudyalso
indicated thatAS isalmostexclusivelydiagnosed inmen.Several recent studies that
included patients with undifferentiated and nonͲradiographic axSpA, however,
demonstrated that thegender ratio ismoreequallydistributed.[17Ͳ19]Malegender
has however been found to be a risk factor for developing radiographic
sacroiliitis.[20,21] Furthermore,patientswith radiographic sacroiliitishave ingeneral
higher inflammatory markers than patients with nonͲradiographic axSpA.[4,22]
IncreasingawarenessamongGPsthataxSpA isequallypresent in femalesandmales,
andmakingthemawareofthe“SpAconcept”,whichincludesaxial,butalsoperipheral
andextraͲarticularmanifestations,willlikelyfacilitatereferralandtimelydiagnosis.
HalfofGPs in thepresentstudywereaware that the therapeuticarmamentarium in
patients with axSpA is broadened with the introduction of antiͲTNFͲalpha therapy.
WhenGPswereaskedaboutthesideͲeffectsofantiͲTNFͲalphatherapy,6GPswerenot
aware of the higher risk of (serious) infections. Collaboration and coͲmanagement








study isqualitativeandthenumberofGPs included issmall.Furthermore,onlymale
andexperiencedGPswere included inthisstudy.SeveralfemaleGPswereasked,but
they unfortunately declined to participate. Logistically, it was extremely difficult to
includerecentlyqualifiedGPs,because intheNetherlandsalmostnoneofthemhave
ownpractices.Wecannotruleoutthatselectionbiasorknowledgebiashasoccurred.
Thismay limit reproducibilityof resultsand theability togeneralize them toawider





Inconclusion,mostGPswere familiarwith“classic”but longͲterm featuresofaxSpA.
Knowledgeaboutparameters indicativeof IBPandawarenessaboutthe fullrangeof
SpAfeatures, includingtheassociatedextraͲarticularmanifestations,was limited.The
diseasespectrumandmanagementofaxSpAhavesubstantiallychangedoverthe last
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recognising and referring patients suspected for having axial or peripheral





SpA,peripheralSpAorcarpal tunnelsyndrome (CTS)with inbetweenaneducational
intervention on SpA for part of the participants. Participantswere unaware of the
natureof themedicalproblemand studypurpose.CTSwas includedasdiversionary
tactic.Theprimaryoutcomewasш40%improvementin(considering)referraloftheSPs
withSpAtotherheumatologistaftereducation.Secondaryoutcomesincludedordering




SixtyͲeight participants (30 GPs and 38 GP residents) were included, of which 19
receivededucation.Theprimaryoutcomewasmet.Asignificantlyhigherproportionof
GP (residents) from the intervention group referred patients to the rheumatologist
comparedwith thecontrolgroupaftereducation (change scores,axialSpA+71%vs.






but targeted educationmarkedly improved this. This supports the development of






an inflammatory rheumatic disorder.[4] Insufficient knowledge might result in a
diagnostic delay, which subsequently may have a negative impact on physical





of 45 years, were classified as having axial SpA after careful evaluation.[9] It is
important toobtain an earlydiagnosis inorder to tailor treatment to the individual
needsof apatient and toprevent adebilitatingdisease course.[10]A shortdisease




increases the probability of a disease in referred patients from 5% to 33Ͳ45%.[18]
However, for successful implementation of such a tool, knowledge about SpA in
primary care is essential.[19,20] A qualitative study involving GPs showed that GPs
wereawareof“classic”,but longͲterm featuresofaxialSpA, i.e.hyperkyphosisanda
bamboospine.Knowledgeabouttheentirediseasespectrum, includingearlydisease,
extraͲarticularmanifestationsandothercharacteristicSpAfeatures,waslimited.[21]
We hypothesised that education with special focus on SpA might improve the
recognitionofSpAfeaturesandearlyreferralofpatientssuspectedforhavingSpA.The
objectivesofthisstudyweretoevaluate(1)thecurrentpracticeperformanceofGPs
andGP residents in recognizing and (considering) referral of patients suspected for
having axial or peripheral SpA, and (2) to assess the influence of education on this





This study is a prospective controlledmulticenter educational intervention study in
primary care. GP residents and their supervising GPs were recruited through the
department of General Practice from the Maastricht University Medical Centre
(MUMC).Every trimester,1Ͳ2group(s)of10Ͳ12GP residentsenter the final yearof
their residency.Once aweek, theymeet  at theMUMC for training.We used this
structure for providing an educational programme, ‘the intervention’, to half of the
groups.Eachgroupwasalternatelyassigned toeither the interventiongroupor the
controlgroup.ThisallocationstrategywasonlyappliedtotheGPresidents.Thegroups
didnothavedirectcontacthourswitheachother.Asimilartrainingstructurewasnot
available for GPs. It was logistically not possible to organize an extra training
conference for GPs without revealing the topic of interest in advance. Therefore,
despiteGPsmaybesupervisinga residentwho received intervention,wedecided to
assignallGPstothecontrolgroup.
The ethics committee of the academic hospitalMaastricht considered this study as
“evaluation and improvement of daily clinical practice”. No further approval was
required. The GP (residents) were informed about SPs visiting their practice for
“evaluation of using SPs in daily practice and education”, and were asked to sign
informedconsent.Nofurtherspecificationwasprovidedonthepurposeofthestudy















of the checklist to secure uniform data quality and comparability. Discrepancies in





for two participants. The CTS casewas included as a diversionary tactic, preventing
premature identification of the objectives of the study, butwas also considered as


























x Disease related items (e.g.onsetof symptoms,presenceof lowbackpain, family
medicalhistory);
x Itemsonphysicalexamination(e.g.ofthejointsand/orback).
The GP (residents) indicated for this specific case which additional diagnostic
investigationstheywouldhaveordered,whichmedicationtheywouldhaveprescribed
(ifany),andwhetherreferraltoanotherhealthcareprofessional(andwhich)wouldbe




























The interactive 3Ͳhour caseͲbased educational programme took place at the




x Axialandperipheral SpA (duration90minutes), i.e. conceptandepidemiologyof
SpA,historytakingandphysicalexaminationofpatientssuspected forhavingSpA,
andcriteriaforreferralofthesepatientstotherheumatologist.






by theGP (resident).Wedecided to combineboth referraland considering referral,
becauseGPsmay spread diagnostic interventions over several consultations or only
refer tosecondarycarewhencomplaints fail toresolvewithina fewweeksafterthe
first consultation. Secondaryoutcomes included (1) correct recognitionof axial SpA,






without education and aimed at increasing this by 40%. In order to detect a 40%
difference inthechangescoresbetweenthe interventiongroupandcontrolgroup in




The difference in change scores between the intervention group and control group
with regard to (considering) referral of the SP and correct recognition of SpAwas
compared with the MannͲWhitney U test. WithinͲgroup changes in referral and
recognitionofSpAbeforeandaftereducationwereanalysedwithMcNemartests.Only
participants that completed both rounds of SP encounters were included in these












Baseline characteristics of the participants are shown in Table 8.1. Three (4%)
participantsmentionedaninterestinmusculoskeletaldisorders.
In total, 256 SP encounters took place, excluding the CTS cases. Both roundswere
completedby61(90%)and59(87%)participantsfortheaxialSpAandperipheralSpA
case, respectively. Reasons for incomplete SP visits were: illness (n=6), unable to
scheduleanappointmentwithinthegiventime frame (n=4), latearrivalbySPdueto










Age[years] 28(1.6) 52(5.9) 39(12.9)
Male 12(32%) 24(80%) 36(53%)
Workingexperience,includingtraining[years] 2(0.4) 22(7.2) 11(10.9)
Weeklyconsultations[number] 62(15.6) 107(26.5) 82(30.6)





ZĞĨĞƌƌĂů ŽĨ ^WƐ ƐŝŵƵůĂƚŝŶŐ ĂǆŝĂů ^Ɖ. In the first round of SP encounters, 6% of the
participants in the intervention group (n=18) and 10% of participants in the control
group (n=43) referredorconsidered referralof theSP to the rheumatologist (Figure
8.2).Participantswhoreceivedtheeducationalprogrammeclearlymoreoftenreferred
 RecognitionandreferralofpatientssuspectedofhavingSpA~149





















ZĞĐŽŐŶŝƚŝŽŶ ŽĨ ĂǆŝĂů ^Ɖ. In the first round of SP encounters, 4 (22%) out of
18participants in the intervention group and 8 (19%) out of 43 participants in the
control group ranked axial SpA as their no. 1 diagnosis.NonͲspecific back painwas
most frequently rankedasno.1diagnosisby10 (56%)outof18participants in the
interventiongroupand31(72%)outof43participantsinthecontrolgroup(Table82).
In total, 34 (56%) out of 68 participants ranked axial SpA as no. 1, 2 or 3 in their
differentialdiagnosisbeforeeducation.
Inthesecondround,theinterventiongroupmorefrequentlyrankedaxialSpAastheir
no. 1 diagnosis (round 1: 22% vs. round 2: 72% (p=0.01); Table 8.2), which was
statistically significantly different from the control group (changes scores: +50%




















































































































































































































































































































































































































































































































































































































































































































































































































GP residentcharacteristicswith regard tocorrect recognitionofaxialSpAwas found










ZĞĐŽŐŶŝƚŝŽŶ ŽĨ ƉĞƌŝƉŚĞƌĂů ^Ɖ͘ In the first round of SP encounters, 2 (11%) out of
19participants in the intervention group and 4 (10%) out of 40 participants in the
controlgrouprankedperipheralSpAas theirno.1diagnosis (Table8.3).Allspecified


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Additionaldiagnostictests    
Radiographyofthehand 0(0%) 2(5%) .50 2(3%)
EMG 3(11%) 3(8%) 1.00 6(9%)
Management    
NSAIDsprescribed 3(8%) 3(11%) .52 6(9%)
Localinjectionwithcorticosteroids 2(7%) 8(22%) .17 10(15%)
Splint 7(25%) 15(41%) .29 22(34%)
FollowͲupconsultationwithGP
(resident)arranged
10(35%) 21(57%) .13 31(47%)
Referraltoneurologist 1(4%) 2(5%) .57 3(5%)





and by 61 (90%) in their top 3 (Table 8.5).No differences between theGP andGP
residentorgenderoftheSPregardingrankingCTSasno.1diagnosiswerefound.Also






























Additionaldiagnostictests    
Radiographyofthehand 0(0%) 2(5%) 0.50 2(3%)
EMG 3(11%) 3(8%) 1.00 6(9%)
Management    
NSAIDsprescribed 3(8%) 3(11%) 0.52 6(9%)
Localinjectionwithcorticosteroids 2(7%) 8(22%) 0.17 10(15%)
Splint 7(25%) 15(41%) 0.29 22(34%)
FollowͲupconsultationwith
GP(resident)arranged
10(35%) 21(57%) 0.13 31(47%)





In this studywe showed thateducation is an importantmeans to change clinicians’
practice behaviour regarding recognition and referral of patients with SpA. While
medicalhistoryandsymptomssimulatedbySPswouldhaveacknowledgedareferralto
a rheumatologist, such apolicywasexecutedbyonly10%of theGPs. Specific SpAͲ
aimededucation improved thispolicydramatically.Theprimaryoutcome,more than
40% improvement in (considering) referral for both axial and peripheral SpA after
education,wasmet.
Approximately 20% of the adult population consult their GP because of





lack knowledge and confidence in this respect.[27Ͳ30] MultiͲfaceted education
interventions, includingmixed interactiveanddidactic learningactivities focussingon
pertinentoutcomeshaveshowntosustainablychangephysicians’behaviour.[31,32]In
thepresentstudy,wealsoappliedmultiͲfacetededucationaltoolsincludinginteractive
powerͲpoint presentations, case vignettes and printed materials, which may have






assessment of physicians’ knowledge and Ͳskills in a ‘genuine’ clinical setting.[23Ͳ
25,33,34]
Severallimitationsofthisstudyrequirediscussion.First,SPsdidnottrulyhavesignsof
their disease detectable at physical examination, which may have jeopardised
recognition. SPs performing a role of peripheral SpA, for example, showed a
photograph with dactylitis to the GP. Dactylitis is a relatively uncommon (albeit
specific)manifestation of peripheral SpA. Nevertheless, one in two GPs (residents)
ranked an inflammatory rheumatic disease as the diagnosis of highest likelihood in























In conclusion, recognition and referral of patients suspected for having SpA by GP
(residents) is in general low, but targeted education can markedly improve this.
Increased awareness of a potential underlying inflammatory condition in patients
presenting with musculoskeletal complaints and timely referral may prevent a
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This thesisdescribes severalstudies that focuson theearly identificationofpatients
withspondyloarthritis(SpA).
As described in Chapter 1,major advances have beenmade over the last years to
facilitateearlydiagnosisofSpA.Oneoftheimportantkeychangeswastheproposalof
the Assessment of SpondyloArthritis international Society (ASAS) to revise disease
nomenclature. Consistent with this proposal, SpA is now categorised into
predominantlyaxial SpA (axSpA)andpredominantlyperipheralSpA.[1Ͳ4] Inaddition,
axSpAhasfurtherbeendifferentiatedas“radiographicaxialSpA”whichissynonymous
to ankylosing spondylitis (AS) and “nonͲradiographic (nr)ͲaxSpA”, in which pelvic
radiographs are normal or equivocal.[1] By recognizing nonͲradiographic axSpA and






manner so that it could be used to better understand disease patterns. This




methodological variables were studied to explain variation in the prevalence of
(subtypesof)SpA inthe84studiesthatwere included.ThepooledprevalenceofSpA
was0.55% (95%confidence interval (CI):0.37Ͳ0.77)and thepooledprevalenceofAS
was0.18%(95%CI:0.15Ͳ0.23).Therewashoweverahighlevelofheterogeneityacross
studies.Substantialvariationbetweengeographicareaswasfound,whichcanpartlybe
explained by the prevalence of HLAͲB27; in populations known to have a high
prevalence of HLAͲB27, a higher prevalence of SpA was reported. The highest
prevalence of SpA (including AS) in our reviewwas reported in decreasing order in
Northern Artic indigenous communities, North America, East Asia and Europe.
Interestingly,prevalenceestimatesofSpAwerepositivelyrelated to theyearofdata
collection.Thisfindingmightbetheresultof increasedawarenessandrecognitionof









In axSpA, the development of new classification criteria was preceded by the
introductionofmagneticresonanceimaging(MRI)oftheSIJ,withtheaimtofacilitate
an early diagnosis of axSpA.[6] The Early SpondyloArthritis Clinic (ESpAC) was
established by our group in order to better understand the role ofMRI in patients
suspected for axSpA. The followͲup study included three full clinical and imaging
examinations performed with one year time intervals.MRIs of the sacroiliac joints
(MRIͲSIJ)wereanintegralpartofthisstudy.Chapter3describestheevolutionofactive
lesionsonMRIͲSIJ,suggestive for sacroiliitis,overa2Ͳyear followͲupperiod.TwentyͲ
four(35%)outof68patientshadapositiveMRIͲSIJatbaseline.Wefoundthatbotha
positiveHLAͲB27statusandpositiveMRIͲSIJatbaselinewereindependentlyassociated








required for a positiveMRIͲSIJ.[9] There is increasing debate, though, if structural
lesions(erosionsorfattylesions)mayalsohaveanindependentdiagnosticvalue.[10]In
Chapter4weinvestigatedthepresenceandevolutionofstructuralchangesonMRIͲSIJ
in patients included in the ESpAC. Subsequently, we analysed whether structural
changes on eitherMRI or pelvic radiographswereprecededbyBME onMRI at the
sameanatomiclocation.ThenumberoferosionsonMRIincreasedsignificantlyduring
followͲup,butthesenewerosionswerenotassociatedwithprecedingBME.Whilethe
numberoffatty lesionsonlyshowedaslight increase,thefewnewfatty lesionswere
associatedwith preceding BME. Interestingly, they occurred preferably in locations
that showed resolution of BME. The relation between inflammation and structural




conflicting results.[14Ͳ17] Our current findings support the view that fatty lesions
shouldbe seen as a repair reaction in response to inflammatory triggers.[19]Other
datahavesuggestedthatfattylesionsonMRIarelinkedtosubsequentdevelopmentof





tau inversion recovery (STIR) sequence, and fatͲsaturated T1Ͳweighted spinͲecho
sequence after administration of the contrast agent gadolinium diethyleneͲ
triaminepentaaceticacid(GdͲDTPA).[9]InChapter5weshowedthatthepostͲGdͲDTPA




All together, it seems as if the postͲGdͲDTPA can safely be omitted. This finding
increases feasibility ofMRI and reduces costs regarding the use ofMRI during the
diagnosticworkͲupofpatientssuspectedforaxSpA.
Atthestartofthisproject,essential informationabouttheuseofMRIwas lacking in
order to recommend it in all patients with a suspicion of axSpA and a normal or
equivocalpelvicradiograph.Oneof thosequestionspertained tohowstablea lesion
foundonMRI isover time.Chapter6describes theexactdistribution, frequencyof
occurrence,andevolutionovertimeofBMEdetectedonMRIͲSIJinpatientsincludedin
theESpAC.Almosthalfof theBME lesionsdetectedatbaseline,had resolvedduring
followͲup.Vice versa, some negative baselineMRIs had become positive over time.
BothhadconsequencesforthefulfilmentoftheASASaxSpAcriteriaatanyfollowͲup
moment. This finding reflects a general concern inherent to diagnostic imaging in
rheumaticconditions,beingthatimagingfindings(whichareinherentlyunreliabledue
to measurement error and judgement variation) become dominant over clinical
findings in theprocessofdiagnosticpattern recognition.Myopically focusingonMRI
reports,forinstance,couldleadtoadelayinthediagnosisofaxSpA,ifsignssuggestive
forsacroiliitisonMRIareabsent inanotherwiseclinicalundisputableSpApatient.On
theotherhand,a focusonMRI findingscould lead toa falsediagnosisofSpA if too




as psoriasis, enthesitis or uveitis should therefore be taken into account. This has
actuallybeendone in the ‘diagnosticalgorithm’ inwhicha thoroughmedicalhistory
andphysicalexaminationareprominentstepsintheworkͲupofpatientssuspectedfor
axSpA, inwhich imaging also plays a role.[8]MRI should only be ordered in those
patientswithareasonablesuspicionforSpA.

Optimizing themanagementofpatientswithSpAalwaysstartswith ‘case finding’. In
theDutchhealthcaresetting,thisusuallystartsinprimarycare.Thelevelofknowledge
andtheperceptionsofgeneralpractitioners(GPs)aboutinflammatorybackpain(IBP)
and axSpA, and potential barriers for referral of patients suspected for axSpAwere
studied inChapter7.WefoundthataxSpA isoftenunrecognized inprimarycare,and
even when recognized, it is often subͲoptimallymanaged. In general, the level of








backpain isacommonsymptom inthegeneralpopulationand it isestimatedthat in
only5%ofcases,axSpA istheunderlyingcondition.[22]GPsmaythinkthatadequate
recognitionofaxSpA isofsecondaryconcern.However, fineͲtuning theprocedure in
ordertoselectthosepatientsthatmayneedfurtherevaluationinsecondarycareisstill
an important step to make. A recent study has shown that 24% of primary care





InChapter8wedescribe the currentpracticeperformanceofGPsandGP residents
withregardtorecognizingearlyaxialorperipheralSpA.Weusedstandardizedpatients
(SPs)todemonstrate‘what isreallygoingon’ indailyclinicalpractice.Inaddition,the
influence of education on this performance was investigated. In this study, 68 GP
residents and their supervising GPs were included and visited by trained SPs who
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simulatedacaseofearlyaxialofperipheralSpA.Weconcluded that recognitionand
referral of patients suspected for SpA to the rheumatologist by GP (residents) is
generally low.Providingeducationhowevermarkedly improvedbothrecognitionand
referralofpatientssuspectedforSpAtotherheumatologist.Educationmaytherefore









us, research results should ratherbe relevantwhenapplied tootherpatientswitha
similarclinicalprofile.AlthoughESpACisarelativelysmallcohort,itclearlyrepresentsa
studypopulationofhighactualinterest.PatientsinESpAChadIBP2yearsatmostand
this cohort is therefore able to providemore insight in the early stages of axSpA.
Patients included in the ESpAC were recruited from the regular rheumatology
outpatient clinic (60%) or by (related) medical specialties (i.e. dermatology,
ophthalmology) and relatives of members of the local AS society (40%). This
recruitmentstrategymayexplainthehighproportionofpatientsfulfillingat leastone
of the classification criteria for SpA (94%). In the ESpAC study, 31 (46%) out of
68patients fulfilled the imaging arm of the ASAS criteria. Although rheumatologists
oftenseepatientsreferredbyothermedicalspecialists,selectingpatients inthisway
mayhampergeneralizabilityofourresultstoawiderpopulationtosomeextent.Our
results may be restricted to patients with a clearer clinical presentation (such as
“psoriasisandIBP”)orthosewithmoreactivedisease.Thismeansthatgeneralization
toanotherpopulation,forexamplepatientswithbackpainreferredbyGPs,shouldbe
donewithcaution. It ishowever important tonote thatourmain researchquestion
was howBME and structural changes onMRIͲSIJ, suggestive for axSpA, evolveover
time. To answer this question, subject restriction by selecting patientswith a high
166~Chapter9
chanceofabnormalitiesonMRIͲSIJmayhaveimprovedefficiencyandinternalvalidity.




In 1968, Barrows was the first to introduce SPs in order to assess the clinical
performance ofmedical residents.[24] Since then, SPs aremost commonly used for
teaching communication and clinical skills.[25] The studywith SPs described in this
thesis,however, focusedonchanges in recognitionofSpAand thedecision to refer
patients to a rheumatologist before and after education. SPs recorded several















The majority of studies that report on educational program innovations focus on




In addition, SP visits have proven to be accurate and reliable in collecting
information.[27Ͳ30] Ina reviewofRethansetal. itwasconcluded thatboth intraͲSP




or chronic conditions, GPs may unfold diagnostic and therapeutic interventions in
severalconsultations.Toovercomethis limitation,we included inthemedicalhistory






ImprovingevidenceͲbasedcareofpatientssuffering fromSpA is theultimategoalof
researchintheSpAͲfield.
New insightsabouttheepidemiologyofSpA,asdescribed inthis thesis,suggest that
spondyloarthritis isasprevalentasrheumatoidarthritis.[31]Theactualprevalenceof
SpA is important for implementingstandardsofcare forpatientswithSpA (including
efforts to diagnose the disease earlier), and for decision makers when allocating
resources to research and healthcare. Knowledge about (variation in) prevalence
contributes to plan optimalquality of carewithin the limits of availablehealth care
resources.
TheintroductionofMRItodiagnosesacroiliitisatanearlystagehasalreadyshownto
be highly useful to both rheumatologists and patients. For rheumatologists, the
introduction ofMRI helps to improve the diagnostic approach of a highly prevalent
clinicalproblem.Whenrheumatologistshavearealsuspicionofaninflammatoryback
probleminapatientaftercarefulevaluation,conventionalpelvicradiographsoftenfail
to show radiographic sacroiliitis. The findings described in this thesis may guide
rheumatologiststocorrectlyassessthevalueofMRIinthesedayͲtoͲdayclinicalcases.
Forinstance,inanHLAͲB27positivemalepatientwithanegativeMRIͲSIJ,asecondMRI
canbeconsidered in caseofpersisting complaints sincea reasonablepercentageof
thesepatientswilldevelopactivelesionsonMRIovertime.
For patients, early diagnosis is important since the pain and physical limitations
associated with axSpAmay have important socioͲeconomic consequences, such as
decreasedwork participation.[32] Substantial diagnostic delay can have an adverse
impactonseveraloutcomes,includingphysicalfunctioningandqualityoflife.[33]Last
butnot least, patientswithnrͲaxSpAwhohaveobjectivemeasuresof inflammation




treatment, therebydiminishing theburdenofdisease forpatientsandpossiblyavoid
longtermcostsofworkdisabilityforsociety.[36]
Optimization of the diagnostic and management process by the rheumatologist is
important,butdecreasingthediagnosticdelayinprimarycareisequallyessential.The












be further validated in prospective studies.[39] Second, further clarification of the








mightbethe firststep inthedominoͲeffect leadingtoboneformation.[44]However,
inflammation and bone formationmight also be (partly) uncoupled processes.New
therapeuticoptionsshouldthenalsoneedtotargetpathwaysofboneͲformation.[11]
Prospective (longitudinal) cohorts are necessary to provide more insight into the




specialist services, it is important that GPs are both informed and motivated to
incorporate the latest insights about SpA into their dailywork practices.[43]Much
attentionhasbeengiven toreferralstrategies,but lackofknowledgeaboutSpAand
absence of incentives for change may prevent successful implementation of any
referral strategy. Therefore, a targeted educational activity should not only include
increaseknowledgeaboutSpA,butalsocreatecommitmentamongGPstochangethe
quality of care for this relatively young patient group.[45Ͳ47] More research is
necessary in order to develop and test educational activities that can ultimately be
usedtosuccessfullyimplementreferralstrategiesinprimarycare.
OVERALLCONCLUSIONS
This thesisshows that thepredictivepotentialofMRIͲSIJ inpatientswithearly IBP is
highwithregardtothepresenceorabsenceofactivelesions,especiallyincombination




important that GPs and rheumatologists learn from each other. Both have
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Bij axiale SpA staan symptomen van het axiale skelet op de voorgrond, met als
overheersende symptoom inflammatoire rugpijn veroorzaakt door sacroͲiliitis
(ontstekingvanhetheiligbeen)en/ofspondylitis (ontstekingvandewervellichamen).
De bekendste vorm van axiale SpA is de aandoening AS, oftewel de ziekte van
Bechterew.[2]BijperifereSpAstaanartritis,enthesitis(inflammatieopdeplaatswaar
pees aan bot vastzit) en dactylitis (worstvormig gezwollen teen of vinger) op de
voorgrond.[2]Intotaalkrijgt40Ͳ50%vandepatiëntenmetSpAtijdenshetbeloopvan
de ziekte een extraͲarticulairemanifestatie, zoals acute uveitis anterior (regenboogͲ
vliesontsteking), inflammatoire darmziekten en psoriasis.[3] SpA begint meestal op
jongvolwassen leeftijd. Aanvang van de eerste klachten na het 45e levensjaar is
zeldzaam.[4]

Bij axiale SpA en in het bijzonder type AS kan uiteindelijk een klassiek radiologisch
beeldmetankyloseringvandesacroͲiliacalegewrichtenopeenbekkenfotozichtbaar
worden.[1] In dewervelkolom kunnen syndesmofyten ontstaan door verbening van
intervertebrale ligamenten.[1]Dit leidtuiteindelijk inhetmeest gevorderde stadium
totvolledigeankylosevandewervelkolom,eenzogehetenbamboospine.Wanneerer
geenofslechtsdubieuzeafwijkingenzichtbaarzijnopeenconventionelebekkenfoto,
kan men besluiten een Magnetic Resonance Imaging (MRI) van de sacroͲiliacale
gewrichten temaken.OpdeMRI kunnen voor sacroͲiliitis kenmerkende afwijkingen
worden gezien, bijvoorbeeld subchondraal beenmergoedeem. Indien de patiënt een
afwijkendeMRIheeft incombinatiemeteenanderSpAkenmerk,danwordtdit‘nietͲ
röntgenologische axiale SpA’ genoemd.[5,6] Bij een aantal patiënten met nietͲ
röntgenologische axiale SpA is sacroͲiliitisop eenMRI (nog) niet aantoonbaar.Deze
patiëntenworden op basis van genetische aanleg (humaan leukocytenantigeen B27




eerste rugklachten voordat de diagnose wordt gesteld.[4] Een belangrijke reden






vanonderdiagnosebij vrouwen.Bij vrouwen zietmenminder structurele schadeop
een conventionele bekkenfoto.[7] Tegenwoordigwordt verondersteld dat de prevaͲ
lentievanaxialeSpAinmannenenvrouwengelijkis.

Eerder onderzoek heeft laten zien dat een goede en tijdige behandeling van SpA
uiteindelijk leidt toteenverbeteringvanverschillendeuitkomstmaten,waaronderde
matevanziekteactiviteit,arbeidsproductiviteitenkwaliteitvanleven.[8Ͳ10]Dehuisarts
is een sleutelfiguurwanneer het gaat om de herkenning en vroege verwijzing van
patiëntenmet klachten die zouden kunnenwijzen op SpA. De afgelopen jaren zijn
verschillendestrategieënontwikkelddieeensnelleverwijzingvanpatiëntenmetSpA
mogelijk zoudenmoetenmaken.[11Ͳ15] Huisartsen hebben echtermoeitemet het
herkennen van het ziektebeeld.[16] Slechte herkenning kan er toe leiden dat de
verwijsstrategieën niet goed worden toegepast in de huisartsenpraktijk. Educatie
specifiek gericht op SpA zou de kennis, herkenning en daardoor verwijzing van
patiëntennaardereumatoloogmogelijkkunnenverbeteren.

De onderzoeken zoals beschreven in dit proefschrift richten zich op de vroege
herkenningvanSpA.
DEELI:DEEPIDEMIOLOGIEVANSPONDYLOARTRITIS
In hoofdstuk 1 wordt beschreven dat er de afgelopen jaren veel is verbeterd ten
aanzien van de mogelijkheden om SpA eerder te diagnosticeren. Een belangrijke
verandering is de ontwikkeling van nieuwe naamgeving door de Assessment in
SpondyloArthritis international Society (ASAS).[17Ͳ20]Momenteelwordtonderscheid
gemaakttussenaxialeSpAenperifereSpA.AxialeSpAwordtverderonderverdeeld in
‘röntgenologische axiale SpA’ ofwel AS en ‘nietͲröntgenologische axiale SpA’, een







over het wereldwijd voorkomen van (de verschillende subtypes van) SpA. Deze
gegevenskunnenwordengebruiktommeerinzichttekrijgeninwelkemaatregelenen
middelen nodig zijn om patiënten met SpA tijdig op te kunnen sporen en te




de variatie in prevalentie tussen de verschillende studies konden verklaren. De
gepooldepopulatieprevalentievanSpAwas0.55%(95%betrouwbaarheidsinterval(BI)
0.37Ͳ0.77); de gepoolde populatieprevalentie van ASwas 0.18% (95% BI 0.15Ͳ0.23).
Tussendegeïncludeerdestudieswerdechtereenhogeheterogeniteitgevonden.De




volgordegevondenbij inheemsebevolkingsgroependie leven inhetArctischgebied,
NoordͲAmerika,OostͲAziëenEuropa.Eenandere interessantebevindingwasdatde
prevalentie van SpAhogerwas in studies vanmeer recentedatum.Wellicht isdeze
stijginginprevalentiedoordejarenheenteverklarendoorhetfeitdatSpAinmiddels
beterwordtherkend.DaarnaastwasprevalentieafhankelijkvandemanierwaaropSpA
werd gedefinieerd. Dit wordt mooi geïllustreerd in een populatiestudie uit de
Verenigde Staten.[21] De prevalentie van SpA was 1.4% wanneer de ESSG criteria
werdengehanteerden0.9%wanneerdeAmorcriteriawerdengehanteerd.Ditverschil
inprevalentiemaaktduidelijkdathet typeclassificatiecriteriauiteindelijk invloedkan
hebbenopdegerapporteerdeprevalentie van (subtypes van)SpA.Het isdaarom te
verwachten dat door het toepassen van de nieuwe ASAS axiale en perifere SpA








immers, in tegenstelling met conventionele röntgenfoto’s, ook kenmerken van




op tweeopeenvolgendeMRIͲsneden,ofwanneer twee laesies aanwezig zijnopéén
MRIͲsnede.[6] De Early SpondyloArthritis Clinic (ESpAC) werd door onze
onderzoeksgroepopgezetommeer inzicht tekrijgen inde rolvanMRIbijpatiënten
met symptomen suggestief voor axiale SpA.De twee jaar durende followͲup studie
bestond uit drie evaluaties met tussenpozen van telkens één jaar. Elke evaluatie
bestondondermeeruiteenuitgebreidklinischonderzoekenbeeldvorming.MRIͲscans
vandesacroͲiliacalegewrichtenmaakteneenbelangrijkonderdeeluitvandezestudie.
Hoofdstuk 3 beschrijft de ontwikkeling van ontstekingsactiviteit op deMRI van de
sacroͲiliacale gewrichten, suggestief voor sacroͲiliitis, gedurende een twee jaar
durende followͲup periode.Op baseline hadden 24 (35%) van de 68 geïncludeerde
patiënteneenpositieveMRIvandesacroͲiliacalegewrichten.Zoweldeaanwezigheid
vanHLAͲB27alseenpositieveMRIopbaseline,warenonafhankelijkgeassocieerdmet











momenteel echter een discussie gaande of structurele afwijkingen (erosies of
beenmergvervetting)ooknieteenonafhankelijkediagnostischewaardehebben.[25]In
hoofdstuk 4 onderzochten we de aanwezigheid en ontwikkeling van structurele
 Samenvatting~179
afwijkingen op een MRI van de sacroͲiliacale gewrichten bij patiënten die zijn
geïncludeerdindeESpAC.Daarnaastwerdgekekenofstructureleafwijkingenopzowel
deMRIalsconventionelebekkenfoto voorafwerdengegaandoorbeenmergoedeem





dat beenmergvervettingmet namewerd gezien op locatieswaar beenmergoedeem
wasverdwenen.DerelatietussenontstekingsactiviteitenstructureleschadeopMRIbij
patiëntenmetaxialeSpA isde laatste jarenvolopbediscussieerd.[26Ͳ33]Dediscussie
richtzichmetnameopdevraagofontstekingsactiviteitenstructureleschade'inrelatie
tot elkaar staan' of 'los van elkaar staan'. Eerder onderzoek laat tegenstrijdige
resultaten zien.[29Ͳ32] Onze bevindingen ondersteunen de theorie dat beenmergͲ
vervettingmogelijk een herstelreactie is op eerder aanwezige ontsteking.[34]Ander
onderzoekheeftaangetoonddatbeenmergvervettingisgeassocieerdmetontwikkeling
van syndesmofieten (benige vergroeiing) in de wervelkolom.[35]Wij vonden geen
associatietussenontstekingsactiviteitopMRIenerzijdsenontwikkelingvanerosiesop




sequentieswordengebruikt.Ditzijndeshort tau inversion recovery (STIR)sequentie
en de T1Ͳgewogen spinͲecho sequentie met onderdrukking van het vetsignaal na
toedieningvanhetcontrastmiddelgadoliniumdiethylenetriaminepentaaceticacid(GdͲ
DTPA).[6] In hoofdstuk 5 lieten we zien dat de postͲGdͲDTPAͲsequentie geen




dus op dat de postͲGdͲDTPAͲsequentie kan worden overgeslagen terwijl de
diagnostische waarde van de MRI behouden blijft. Deze bevinding leidt tot een
kostenbesparing en vergroot daarmee de toepasbaarheid van de MRI wanneer




Bij aanvang van dit promotieonderzoekwas ernog veelonduidelijkheid omtrentde
toepasbaarheidvanMRI.Deaanbevelingdatallepatiëntenmetklachtenverdachtvoor
axialeSpAeneennegatievebekkenfotoeenMRIzoudenmoetenondergaan,konnog
niet hardworden gemaakt. Een belangrijke vraagwas of beenmergoedeem opMRI





beenmergoedeem op een aantal MRI’s tijdens followͲup vastgesteld, terwijl de
voorafgaandeMRIopbaselinenegatiefwas. Inbeidegevallenhadditgevolgenvoor
hetaldannietvoldoenaandeASASaxialeSpAclassificatiecriteria.Ditlaatziendathet
toepassen van beeldvormende technieken om een reumatische aandoening te
diagnosticeren ook beperkingenmet zichmeebrengt. Bevindingen bij beeldvorming
zijn immers altijd onderhevig aanmeetfouten van beoordelaars en variatie tussen
beoordelaars; beeldvormingmoet daarom geen belangrijkere rol toebedeeld krijgen
dandebevindingentijdensanamneseenklinischonderzoek.‘Blindstaren’opeenMRIͲ








Dit gegeven komt eveneens terug in een recent ontwikkeld ‘diagnostisch algoritme’
waarineengedegenanamneseenlichamelijkonderzoekonmisbarestappenzijnbijde
beoordeling van een patiëntmet verdenking op axiale SpA.[24] Alleen wanneer er








patiëntenmet SpAbegintdusaltijdmet zogenaamde ‘case finding’.Ditproces start
meestal in de eerste lijn. In hoofdstuk 7 werden zowel het kennisniveau als de
percepties van huisartsen over inflammatoire rugpijn en axiale SpA bestudeerd.
Daarnaast werd gekeken welke potentiële barrières een tijdige verwijzing van
patiëntenmetmogelijkaxialeSpAverhinderen.We toondenaandataxialeSpAvaak
nietgoedindeeerstelijnwordtherkend.Zelfswanneerhetwelwordtherkend,danis
de zorg rondom deze patiënten vaak suboptimaal. In het algemeenwas de kennis
omtrent inflammatoire rugpijn, axiale SpA enextraͲarticulairemanifestatiesbeperkt.
Huisartsen herkenden veelal slechts de ‘klassieke’, maar langetermijngevolgen van
axialeSpA,zoalsbijvoorbeeldeenkyfosediewordtgezienbijAS.Slechtsdehelftvan
degeïnterviewdehuisartsenwistdatTumorNecrosisFactor (TNF)Ͳalphablokkerende
biologicals, een erkende en effectieve behandeling bij een specifieke groep van
patiënten met bij axiale SpA, een behandeloptie zijn bij deze patiëntengroep.
Vergroten van kennis bij huisartsen aangaande de symptomen en behandeling van
axialeSpA, zalwaarschijnlijkdeverwijzingvanpatiëntenmetklachtenverdachtvoor
axialeSpAbevorderen.
In de dagelijkse praktijkmoet de huisarts adequaat kunnen anticiperen op velerlei
lichamelijkeenpsychischeklachtenwaarpatiëntenzichmeepresenteren.Herkenning




selecteren die wel dienen te worden verwezen naar de tweedelijn, is echter een
belangrijkenogtemakenstap.Eenrecentestudieheeftlatenziendatbijnaeenkwart
van de patiëntenmet chronische rugpijn die ontstond voor de leeftijd van 45 jaar
geclassificeerd kon worden met axiale SpA nadat de huisarts deze patiënten had
verwezennaardereumatoloog.[38]
DehuisartsisonmisbaarbijhetherkennenvanpatiëntenmetSpA.Huisartsenverkeren




In hoofdstuk 8 onderzochten we in hoeverre huisartsen en huisartsen in opleiding
(HAIO)vroegeaxialeenperifereSpAherkennenenverwijzen.Wemaaktengebruikvan
simulatiepatiëntenom teonderzoeken ‘hoeheter indepraktijkechtaan toegaat’.
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Daarbij kekenwe ook naar de invloed van educatie op demate van herkenning en
uiteindelijk verwijzing. In totaal werden 68 huisartsen en HAIO’s bezocht door
simulatiepatiëntendiewarengetraindomeencasusvanvroegeaxialedanwelperifere
SpA te simuleren. We bevestigden dat zowel de herkenning als verwijzing van
patiëntenmetklachtensuggestiefvoorSpAslechtsbeperktwas.Educatieverbeterde
duidelijkdeherkenningenverwijzingvanpatiëntennaarde reumatoloog.Hetgeven
van onderwijs lijkt daarmee een belangrijke kans om de kenniswat betreft SpA te
verbeteren, waardoor een succesvolle implementatie van een verwijsstrategie
dichterbijkomt.
PERSPECTIEF
In hoofdstuk 9 werden bevindingen uit dit proefschrift samengevat en enkele
methodologische aspecten verderbediscussieerd. Teneerstewerd stilgestaanbijde
generaliseerbaarheid van de resultaten die zijn verkregen uit het ESpACͲonderzoek.
Patiëntendiewerdengeïncludeerd indeESpACwarenreedsverdachtophethebben
vanSpAen warenverwezendoorde reumatoloogofdoormedisch specialistendie




nietmeteen te generaliseren zijn naar patiëntenmet eenminder duidelijk klinisch




Ten tweedewerden de voorͲ en nadelen van het gebruik van simulatiepatiënten in
onderzoekbesproken.Doorsimulatiepatiëntenintezettenwarenwijinstaattekijken
ofeducatieuiteindelijkookeengedragsverandering ingang zet.Ditgaatdus verder
danhetafnemenvaneen toetsnaeeneducatiemoment.Onze resultaten laten zien
dat simulatiepatiënten ook ingezet kunnenworden bijmeer ingewikkeldemedische
problemen zoals bijvoorbeeld SpA. Er zijn danwelmeer voorbereidingsmaatregelen
nodig. Specifiek in ons onderzoek was het bijvoorbeeld belangrijk om een goede
voorgeschiedenisoptestelleneneennauwkeurigebeschrijvingtegevenvandereeds
ondernomen stappen, zoals het effect van eerder ontvangen fysiotherapie op de
klachten.
 Samenvatting~183
Ten slotte werden er aanbevelingen gedaan voor de klinische praktijk en verder
onderzoek.Met de introductie van deMRI van de sacroͲiliacale gewrichten is de
reumatoloog in staatgesteldompatiëntenmetSpAeerdereendiagnose tekunnen
gevenenhierdoor,indiennodig,tijdigtestartenmeteenbehandeling.Hetonderzoek
beschreveninditproefschriftkanreumatologenhelpenhoezedeMRIindedagelijkse
praktijk kunnen inzetten. Meer onderzoek is echter nodig om onder andere de
diagnostischewaardevanstructureleveranderingenopeenMRIvasttestellen.
Snel instellen van een behandeling leidt mogelijk tot minder werkverzuim en
arbeidsongeschiktheid. Om het gunstige effect van een vroege diagnose op de
verschillendeuitkomstmatenoptimaaltebenutten,ishetwelbelangrijkdatpatiënten
ooksnelwordenverwezen.Wijhebben latenziendateducatieaanhuisartsenhierbij
kan helpen. Meer onderzoek is nodig om te kijken welke onderwijsactiviteiten
bijdragenaaneensuccesvolleverwijsstrategieis.Bijhetbewerkstelligenvanditdoelis
hetbelangrijkterealiserendatreumatologenenhuisartsenhierbijvanelkaarkunnen
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and familyby reducedparticipation in social roles.[3,4]The indirect costs related to
SpAare fourtimesashighasthedirectcosts,reflectingthe important impactofthe
disease on work participation in terms of sick leave, disability pensions and early
retirement.[5] To extrapolate how this individual burden would affect society,
appropriatedataontheepidemiologyarewarranted.Inthisthesis,wefoundthatthe
global prevalence of SpAwas 0.55% (95% Confidence Interval (CI): 0.37Ͳ0.77). This
prevalence iscomparable to thatofrheumatoidarthritis.Substantialvariationacross
geographicregionswashoweverfound.Forinstance,theprevalenceofSpAinEastAsia
was 0.79% (CI: 0.48Ͳ1.18). The study described in this thesis adds to the available





of axial SpA (axSpA),making an early diagnosis possible. This thesis showed that a
positiveMRIisareliablefinding:apositiveMRIatbaselinewasstronglyassociatedwith
a positiveMRI of the sacroiliac joints (MRIͲSIJ) over time, particularly in HLAͲB27
positivepatients.Thisisimportantforclinicians,becauseitsuggeststhatadiagnosisof




Further, in axSpA it is a challenge to identify the appropriate target for treatment:
should itbediseaseactivity,preventionordelay inprogressionofstructuraldamage,













2010 study found thatMSD, including rheumatic disorders,were the secondmain
contributor to the number of years lived with disability.[1] Part of this burden is
avoidable.The importanceofMSDasmajorcauseof (avoidable)disability,however,





opportunities for early recognition and referral have been missed in primary
care.[18,19]SeveralreferralstrategiesthatpromoteearlyreferralofaxSpAhavebeen
developed, but successful implementationmay be hampered by ineffective referral
patternsdue to lackofknowledgeaboutaxSpA.[20Ͳ23]From this thesis,we learned
thatthereisroomforimprovementwithregardtothelevelofknowledgeofGPsabout
their ability to identify and refer patients with suspected axSpA. Changing clinical
practice behavior and assessing such change is a real challenge. The evidence that
educationalinterventionsmayactuallychangeanythingislimited.[24]Lackoftimeand
resources often contribute to failure of the education intervention.[24] This thesis
shows that the use of standardized patients (SPs), is a feasible and informative
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zijn/haar bijdrage heeft geholpen. Ik wil deze pagina’s gebruiken om een aantal
menseninhetbijzondertebedanken.

Ten eerste wil ik alle patiënten van het ESpAC cohort bedanken voor hun
medewerking, zonder jullie zou er voormij niet veel te onderzoeken zijn geweest.
Daarnaast wil ik alle simulatiepatiënten, huisartsen en huisartsenͲinͲopleiding






moment spijt vangehad. Ikhoopdat jijdatookniethebtgehad… Zekeromdathet
allemaal ietsmeertijdheeftgekostdannormaal. Ikhebveelvan jegeleerdenwil je
bedankenvoorjevertrouwen,geduld,kritischeblikenhumor.

Prof. dr. Boonen, beste Annelies,wat ben ik blij dat ik nu steedsmeermet je kan
samenwerken!Ondanks jeeigendrukkeprogrammaben je altijdbereidommee te










Prof. dr. van der Heijde, beste Désirée, eigenlijk heb jij het fundament voor dit






R.A. de Bie, Prof. dr. F. van den Bosch, Prof. dr. J.A. Knottnerus,Dr.A.E.A.M.Weel
bedankenvoorhetinhoudelijkcommentaar,adviezenendegoedkeuring.
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Veel mensen hebben essentiële bijdrage geleverd aan de totstandkoming van
verschillende artikelen. Dr. Jurik, dear Anne Grethe, I would like to thank you for
helpingme to score all thoseMRIs, in only four days.We finished scoring just ten
minutesbeforeIhadtoleavetocatchmyflightbackhome!Ienjoyedworkingtogether
withyou.Dr.Heuft,Liesbeth,dankzij jouw investering inhetESpACcohortben ik in
staat gesteld om verder aan de slag te gaan met de followͲup gegevens. Dank
daarvoor! Dr. Gorter, Dr.Maiburg, Drs.Waagenaar, beste Simone, Bas en Gerrie,
bedankt voor de prettige samenwerking en jullie enthousiasme bij het opzetten en
uitvoeren van het simulatiepatiëntenproject.Aniek en Carmen, hetwas erg leuk en
gezelligommetjullieonderzoektemogendoen.

Een proefschrift kan natuurlijk alleenmaar worden geschreven als je daarvoor de
ruimte enmogelijkheden krijgt.Debby, Thea,Caroline, Sandrine,bedankt voor jullie
concrete hulp of steuntje in de rug op het juistemoment.Debby, ikwil jou in het
bijzonderookbedankenvoordekansdie jemijhebtgebodenomme inMaastricht
verdertemogenontwikkelen.Jemoetnutocheensgaanwinkelenvooreenmooietas,







vertrouwen inmij.Dankzij u kon ik startenmet de opleiding tot reumatoloog, een
prachtigcadeau!

Mijn opleiding heb ikmogen voltooien in Heerlen.Wat heb ik daar een leuke tijd
gehad! Ik wil graag alle reumatologen, AIOS reumatologie, reumaconsulenten en
polimedewerkers bedanken. Mede dankzij jullie inzet heb ik dat jaar echt tempo
 Dankwoord~197
kunnenmaken en veelwerk kunnen verzetten. Een bijzonderwoord van dank aan
Mirian en Ralph, dankzij jullie uitstekende begeleiding kunnen AIOS in Heerlen het










opbeurende woorden als iets weer niet helemaal ging zoals ik van te voren had






kan ikme nogmeerwensen? Jullie helpenme altijd perfectmet de administratie.
Dankzijjulliehebikgeleerddathetsomsechtbeteriswanneerjedezakenuithanden
geeft. Edith, Maddy en Marjos, jullie zijn voor mij het gezicht van de polikliniek
reumatologieenzorgenervoordatmijnspreekuursoepel loopt.Erverandertnuveel
op de polikliniek,maar ikweet zeker datwe er ietsmoois van gaanmaken. Tiny,
bedanktvoorjehulpbijdelayͲoutvanhetproefschrift.

De eerste jaren van mijn opleiding heb ik doorgebracht op de afdeling interne
geneeskundevanhetMUMC. IkwilProf.dr.C.StehouwerenProf.dr.R.Koopmans
bedanken voor het verzorgen van een gedegen vooropleiding en de vrijheid om





gezelligheid en afleiding geboden. Floor, ik ken je al vanaf de eerste klas van de









Berdien en Corrie, nogmaals dank voor jullie hulp bij het opknappen vanmijn huis.
































haar gymnasiumdiploma aan het Kandinsky College in Nijmegen, studeerde zij van
2000tot2002GezondheidswetenschappenaandeuniversiteitvanMaastricht.In2002
besloot zij Geneeskunde te gaan studeren, omdat zij bij nader inzien toch geen








proefschrift werden gepresenteerd op verschillende nationale en internationale
congressen.Devervolgopleidingtotreumatoloogwerdin2012voortgezetinzowelhet
MUMCalshetZuyderlandZiekenhuisinHeerlen(opleiders:Prof.dr.S.vanderLinden,
Dr.D.VosseenDr.R.Peeters).
Sinds2015werktzijalsstaflidReumatologieinhetMUMC.
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